Alpha-tocopherol	O
inhibits	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
to	O
cultured	B-cell_line
human	I-cell_line
endothelial	I-cell_line
cells	I-cell_line
.	O

Antioxidants	O
have	O
been	O
proposed	O
to	O
be	O
anti-atherosclerotic	O
agents	O
;	O
however	O
,	O
the	O
mechanisms	O
underlying	O
their	O
beneficial	O
effects	O
are	O
poorly	O
understood	O
.	O

We	O
have	O
examined	O
the	O
effect	O
of	O
alpha-tocopherol	O
(	O
alpha-tcp	O
)	O
on	O
one	O
cellular	O
event	O
in	O
atherosclerotic	O
plaque	O
development	O
,	O
monocyte	O
adhesion	O
to	O
stimulated	B-cell_type
endothelial	I-cell_type
cells	I-cell_type
(	O
ECs	B-cell_type
)	O
.	O

Human	O
umbilical	O
vein	O
ECs	B-cell_type
were	O
pretreated	O
with	O
alpha-tcp	O
before	O
stimulation	O
with	O
known	O
agonists	O
of	O
monocyte	O
adhesion	O
:	O
IL-1	B-protein
(	O
10	O
ng/ml	O
)	O
,	O
LPS	O
(	O
10	O
ng/ml	O
)	O
,	O
thrombin	B-protein
(	O
30	O
U/ml	O
)	O
,	O
or	O
PMA	O
(	O
10	O
nM	O
)	O
.	O

Agonist-induced	O
monocytic	O
cell	O
adhesion	O
,	O
but	O
not	O
basal	O
adhesion	O
,	O
was	O
inhibited	O
in	O
a	O
time-	O
and	O
concentration-dependent	O
manner	O
by	O
alpha-tcp	O
.	O

The	O
IC50	O
of	O
alpha-tcp	O
on	O
an	O
IL-1	B-protein
-induced	O
response	O
was	O
45	O
microM	O
.	O

The	O
inhibition	O
correlated	O
with	O
a	O
decrease	O
in	O
steady	O
state	O
levels	O
of	O
E-selectin	B-RNA
mRNA	I-RNA
and	O
cell	O
surface	O
expression	O
of	O
E-selectin	B-protein
which	O
is	O
consistent	O
with	O
the	O
ability	O
of	O
a	O
monoclonal	B-protein
antibody	I-protein
to	O
E-selectin	B-protein
to	O
inhibit	O
monocytic	O
cell	O
adhesion	O
in	O
this	O
system	O
.	O

Probucol	O
(	O
50	O
microM	O
)	O
and	O
N-acetylcysteine	O
(	O
20	O
mM	O
)	O
also	O
inhibited	O
agonist-induced	O
monocytic	O
cell	O
adhesion	O
;	O
whereas	O
,	O
several	O
other	O
antioxidants	O
had	O
no	O
significant	O
effect	O
.	O

Protein	B-protein
kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
does	O
not	O
appear	O
to	O
play	O
a	O
role	O
in	O
the	O
alpha-tcp	O
effect	O
since	O
no	O
suppression	O
of	O
phosphorylation	O
of	O
PKC	B-protein
substrates	O
was	O
observed	O
.	O

Activation	O
of	O
the	O
transcription	B-protein
factor	I-protein
NF-kappa	B-protein
B	I-protein
is	O
reported	O
to	O
be	O
necessary	O
but	O
not	O
sufficient	O
for	O
E-selectin	B-protein
expression	O
in	O
EC	B-cell_line
.	O

Electrophoretic	O
mobility	O
shift	O
assays	O
failed	O
to	O
show	O
an	O
alpha-tcp-induced	O
decrease	O
in	O
activation	O
of	O
this	O
transcription	B-protein
factor	I-protein
after	O
cytokine	B-protein
stimulation	O
.	O

It	O
has	O
been	O
hypothesized	O
that	O
alpha-tcp	O
acts	O
as	O
an	O
anti-atherosclerotic	O
molecule	O
by	O
inhibiting	O
generation	O
of	O
oxidized	O
LDL	O
--	O
a	O
putative	O
triggering	O
molecule	O
in	O
the	O
atherosclerotic	O
process	O
.	O

Our	O
results	O
point	O
to	O
a	O
novel	O
alternative	O
mechanism	O
of	O
action	O
of	O
alpha-tcp	O
.	O

a	NULL
«	NULL
-Tocopherol	NULL
Inhibits	NULL
Agonist-induced	NULL
Monocytic	NULL
Cell	NULL
Adhesion	NULL
to	NULL
Cultured	NULL
Human	NULL
Endothelial	NULL
Cells	NULL
Rishad	NULL
Faruqi	NULL
,	NULL
Carol	NULL
de	NULL
la	NULL
Motte	NULL
,	NULL
and	NULL
Paul	NULL
E.	NULL
DiCorieto	NULL
Department	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
Research	NULL
Institute	NULL
of	NULL
The	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
44195	NULL
Abstract	NULL
Antioxidants	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
anti-atherosclerotic	NULL
agents	NULL
;	NULL
however	NULL
,	NULL
the	NULL
mechanisms	NULL
underlying	NULL
their	NULL
beneficial	NULL
effects	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
a-tocopherol	NULL
(	NULL
a-tcp	NULL
)	NULL
on	NULL
one	NULL
cellular	NULL
event	NULL
in	NULL
atherosclerotic	NULL
plaque	NULL
development	NULL
,	NULL
monocyte	NULL
adhesion	NULL
to	NULL
stimulated	NULL
endothelial	NULL
cells	NULL
(	NULL
ECs	NULL
)	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
ECs	NULL
were	NULL
pretreated	NULL
with	NULL
a-tcp	NULL
before	NULL
stimulation	NULL
with	NULL
known	NULL
agonists	NULL
of	NULL
monocyte	NULL
adhesion	NULL
:	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
,	NULL
thrombin	NULL
(	NULL
30	NULL
U/ml	NULL
)	NULL
,	NULL
or	NULL
PMA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
.	NULL

Agonist-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
,	NULL
but	NULL
not	NULL
basal	NULL
adhesion	NULL
,	NULL
was	NULL
inhibited	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
concentration-dependent	NULL
manner	NULL
by	NULL
a-tep	NULL
.	NULL

The	NULL
IC	NULL
,	NULL
,	NULL
of	NULL
a-tep	NULL
on	NULL
an	NULL
IL-1-induced	NULL
response	NULL
was	NULL
45	NULL
pM	NULL
.	NULL

The	NULL
inhibition	NULL
correlated	NULL
with	NULL
a	NULL
decrease	NULL
in	NULL
steady	NULL
state	NULL
levels	NULL
of	NULL
E-selectin	NULL
mRNA	NULL
and	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
E-selectin	NULL
to	NULL
inhibit	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
in	NULL
this	NULL
system	NULL
.	NULL

Probucol	NULL
(	NULL
50	NULL
mM	NULL
)	NULL
and	NULL
N-acetylcysteine	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
also	NULL
inhibited	NULL
agonist-induced	NULL
monocytic	NULL
cell	NULL
adhe-sion	NULL
;	NULL
whereas	NULL
,	NULL
several	NULL
other	NULL
antioxidants	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
a-tep	NULL
effect	NULL
since	NULL
no	NULL
suppression	NULL
of	NULL
phosphorylation	NULL
of	NULL
PKC	NULL
substrates	NULL
was	NULL
observed	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-B	NULL
is	NULL
reported	NULL
to	NULL
be	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
E-selectin	NULL
expression	NULL
in	NULL
EC	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
failed	NULL
to	NULL
show	NULL
an	NULL
a-tep-induced	NULL
decrease	NULL
in	NULL
activation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
after	NULL
cytokine	NULL
stimulation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
hypothesized	NULL
that	NULL
a-tep	NULL
acts	NULL
as	NULL
an	NULL
anti-atherosclerotic	NULL
molecule	NULL
by	NULL
inhibiting	NULL
generation	NULL
of	NULL
oxidized	NULL
LDL-a	NULL
putative	NULL
triggering	NULL
molecule	NULL
in	NULL
the	NULL
atherosclerotic	NULL
process	NULL
.	NULL

Our	NULL
results	NULL
point	NULL
to	NULL
a	NULL
novel	NULL
alternative	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
a-tcp	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1994	NULL
.	NULL

94:592-600	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
antioxidants	NULL
«	NULL
NF-	NULL
«	NULL
B	NULL
«	NULL
U937	NULL
cell	NULL
«	NULL
atherosclerosis	NULL
Introduction	NULL
The	NULL
role	NULL
of	NULL
monocytes	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
atherosclerosis	NULL
is	NULL
well	NULL
recognized	NULL
and	NULL
the	NULL
adhesion	NULL
of	NULL
blood-borne	NULL
monocytes	NULL
to	NULL
the	NULL
endothelium	NULL
of	NULL
lesion-prone	NULL
regions	NULL
of	NULL
the	NULL
vasculature	NULL
is	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
documented	NULL
events	NULL
in	NULL
numerous	NULL
animal	NULL
mod	NULL
Address	NULL
correspondence	NULL
to	NULL
Paul	NULL
E.	NULL
DiCorleto	NULL
,	NULL
Ph.D.	NULL
,	NULL
Department	NULL
of	NULL
Cell	NULL
Biology-NC10	NULL
,	NULL
Cleveland	NULL
Clinic	NULL
Research	NULL
Institute	NULL
,	NULL
9500	NULL
Euclid	NULL
Avenue	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
44195	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
16	NULL
July	NULL
1993	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
7	NULL
March	NULL
1994	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/94/08/0592/09	NULL
-	NULL
$	NULL
2.00	NULL
Volume	NULL
94	NULL
,	NULL
August	NULL
1994	NULL
,	NULL
592-600	NULL
592	NULL
Faruqi	NULL
et	NULL
al	NULL
.	NULL

els	NULL
of	NULL
atherosclerosis	NULL
(	NULL
1-7	NULL
)	NULL
.	NULL

Altered	NULL
or	NULL
dysfunctional	NULL
endothelium	NULL
expresses	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
va-soactive	NULL
compounds	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
attract	NULL
,	NULL
activate	NULL
,	NULL
and	NULL
cause	NULL
the	NULL
transendothelial	NULL
migration	NULL
of	NULL
monocytes	NULL
(	NULL
8-12	NULL
)	NULL
.	NULL

Monocyte	NULL
adhesion	NULL
to	NULL
activated	NULL
endothelial	NULL
cells	NULL
(	NULL
EC	NULL
's	NULL
)	NULL
!	NULL

in	NULL
vitro	NULL
therefore	NULL
serves	NULL
as	NULL
a	NULL
useful	NULL
model	NULL
to	NULL
simulate	NULL
the	NULL
early	NULL
cellular	NULL
events	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
atherosclerosis	NULL
.	NULL

The	NULL
direct	NULL
mechanism	NULL
of	NULL
EC	NULL
activation	NULL
in	NULL
vivo	NULL
is	NULL
unknown	NULL
.	NULL

Free	NULL
radical-mediated	NULL
injury	NULL
,	NULL
either	NULL
direct	NULL
or	NULL
indirect	NULL
(	NULL
by	NULL
the	NULL
generation	NULL
of	NULL
oxidized	NULL
lipoproteins	NULL
in	NULL
the	NULL
micro-environment	NULL
of	NULL
the	NULL
endothelium	NULL
)	NULL
,	NULL
is	NULL
one	NULL
proposed	NULL
mechanism	NULL
by	NULL
which	NULL
EC	NULL
are	NULL
rendered	NULL
pro-atherogenic	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

Biological	NULL
response	NULL
modifi-ers	NULL
,	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
LPS	NULL
,	NULL
thrombin	NULL
,	NULL
and	NULL
PMA	NULL
,	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
endothelium	NULL
and	NULL
cause	NULL
enhanced	NULL
monocyte	NULL
adhesion	NULL
in	NULL
vitro	NULL
.	NULL

One	NULL
way	NULL
in	NULL
which	NULL
such	NULL
diverse	NULL
substances	NULL
may	NULL
act	NULL
is	NULL
by	NULL
the	NULL
intracellular	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
that	NULL
serve	NULL
as	NULL
second	NULL
messengers	NULL
in	NULL
gene	NULL
activation	NULL
(	NULL
16-20	NULL
)	NULL
.	NULL

a	NULL
«	NULL
-Tocopherol	NULL
(	NULL
a-tep	NULL
)	NULL
or	NULL
vitamin	NULL
E	NULL
,	NULL
a	NULL
lipid-soluble	NULL
vitamin	NULL
and	NULL
biological	NULL
response	NULL
modifier	NULL
,	NULL
is	NULL
a	NULL
chain-breaking	NULL
tissue	NULL
antioxidant	NULL
(	NULL
21	NULL
)	NULL
.	NULL

A	NULL
ubiquitous	NULL
molecule	NULL
present	NULL
at	NULL
low	NULL
concentrations	NULL
in	NULL
all	NULL
biomembranes	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
an	NULL
anti-atherogenic	NULL
agent	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Though	NULL
the	NULL
mechanism	NULL
of	NULL
a-tep	NULL
action	NULL
has	NULL
not	NULL
been	NULL
rigorously	NULL
demonstrated	NULL
,	NULL
it	NULL
has	NULL
been	NULL
hypothesized	NULL
that	NULL
it	NULL
acts	NULL
through	NULL
inhibiting	NULL
generation	NULL
of	NULL
oxidized	NULL
LDL-a	NULL
putative	NULL
triggering	NULL
molecule	NULL
in	NULL
the	NULL
atherosclerotic	NULL
process	NULL
.	NULL

a-tep	NULL
is	NULL
believed	NULL
to	NULL
act	NULL
as	NULL
a	NULL
cytoprotective	NULL
agent	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
pathophysiological	NULL
processes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

-tep	NULL
is	NULL
also	NULL
thought	NULL
to	NULL
be	NULL
an	NULL
immune	NULL
modulator	NULL
,	NULL
enhancing	NULL
both	NULL
cell-mediated	NULL
and	NULL
humoral	NULL
immunity	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
cytoprotective	NULL
effect	NULL
of	NULL
a-tep	NULL
is	NULL
attributed	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
act	NULL
as	NULL
a	NULL
scavenger	NULL
of	NULL
highly	NULL
reactive	NULL
oxygen	NULL
radicals	NULL
,	NULL
thus	NULL
stabilizing	NULL
membranes	NULL
against	NULL
lipid	NULL
peroxidation	NULL
(	NULL
26-29	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
signaling	NULL
events	NULL
involved	NULL
in	NULL
mediating	NULL
monocyte	NULL
adhesion	NULL
to	NULL
activated	NULL
EC	NULL
are	NULL
not	NULL
fully	NULL
defined	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
,	NULL
a	NULL
family	NULL
of	NULL
isoenzymes	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
a	NULL
number	NULL
of	NULL
intracellular	NULL
events	NULL
involved	NULL
in	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
,	NULL
receptor	NULL
down-regulation	NULL
,	NULL
cell	NULL
activation	NULL
,	NULL
transformation	NULL
,	NULL
and	NULL
proliferation	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
1-	NULL
(	NULL
S-isoquinolinesulfonyl	NULL
)	NULL
-2-methylpiperazine	NULL
di-hydrochloride	NULL
(	NULL
H-7	NULL
)	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
PKC	NULL
,	NULL
abolishes	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
,	NULL
suggesting	NULL
that	NULL
PKC	NULL
activation	NULL
may	NULL
be	NULL
necessary	NULL
for	NULL
this	NULL
process	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
a-tcp	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
PKC	NULL
in	NULL
rat	NULL
brain	NULL
homogenates	NULL
(	NULL
33	NULL
)	NULL
,	NULL
permeabilized	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
and	NULL
neuroblastoma	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Another	NULL
potential	NULL
site	NULL
of	NULL
action	NULL
of	NULL
a-tcp	NULL
in	NULL
abrogating	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
is	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
tran	NULL
1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
a-tep	NULL
,	NULL
a-tocopherol	NULL
;	NULL
BHT	NULL
,	NULL
butylated	NULL
hydroxytoluene	NULL
;	NULL
DPPD	NULL
,	NULL
N	NULL
,	NULL
N-diphenyl-1,4-phenylene	NULL
diamine	NULL
;	NULL
EC	NULL
,	NULL
endothelial	NULL
cells	NULL
;	NULL
MARCKS	NULL
,	NULL
myristoylated	NULL
alanine-rich	NULL
C	NULL
kinase	NULL
substrate	NULL
;	NULL
NAC	NULL
,	NULL
N-acetylcysteine	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C.	NULL
scription	NULL
factor	NULL
,	NULL
NF-kB	NULL
.	NULL

E-selectin	NULL
,	NULL
an	NULL
endothelial	NULL
adhesion	NULL
molecule	NULL
first	NULL
cloned	NULL
and	NULL
characterized	NULL
by	NULL
Bevilacqua	NULL
et	NULL
al	NULL
.	NULL

(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
an	NULL
important	NULL
player	NULL
in	NULL
monocyte	NULL
adhesion	NULL
to	NULL
EC	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
contains	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
39	NULL
)	NULL
.	NULL

This	NULL
transcription	NULL
factor	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
necessary	NULL
in	NULL
regulating	NULL
transcription	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
(	NULL
40	NULL
)	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
PKC	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
can	NULL
be	NULL
potential	NULL
target	NULL
sites	NULL
for	NULL
the	NULL
action	NULL
of	NULL
a-tcp	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
a-tcp	NULL
on	NULL
stimulated	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
to	NULL
EC	NULL
and	NULL
the	NULL
sites	NULL
along	NULL
the	NULL
signaling	NULL
pathways	NULL
of	NULL
E-selectin	NULL
expression	NULL
that	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
mediating	NULL
the	NULL
effect	NULL
of	NULL
a-top	NULL
.	NULL

Methods	NULL
Cell	NULL
culture	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
ECs	NULL
were	NULL
isolated	NULL
by	NULL
a	NULL
technique	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
by	NULL
Lewis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
,	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
collected	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
seeded	NULL
into	NULL
fibro-nectin-coated	NULL
flasks	NULL
(	NULL
5	NULL
ug/ml	NULL
rabbit	NULL
fibronectin	NULL
)	NULL
under	NULL
the	NULL
conditions	NULL
described	NULL
by	NULL
Thornton	NULL
et	NULL
al	NULL
.	NULL

(	NULL
44	NULL
)	NULL
and	NULL
grown	NULL
in	NULL
DME/F12	NULL
media	NULL
(	NULL
Irvine	NULL
Scientific	NULL
Co.	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
supplemented	NULL
with	NULL
15	NULL
%	NULL
FBS	NULL
,	NULL
heparin	NULL
(	NULL
90	NULL
ug/ml	NULL
)	NULL
,	NULL
endothelial	NULL
cell	NULL
growth	NULL
factor	NULL
(	NULL
150	NULL
pg/ml	NULL
)	NULL
,	NULL
sodium	NULL
bicarbonate	NULL
(	NULL
0.24	NULL
%	NULL
)	NULL
,	NULL
MEM	NULL
non-essential	NULL
amino	NULL
acids	NULL
(	NULL
0.1	NULL
mM	NULL
)	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
U/	NULL
ml	NULL
)	NULL
,	NULL
and	NULL
streptomycin	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

EC	NULL
were	NULL
used	NULL
between	NULL
the	NULL
first	NULL
and	NULL
fourth	NULL
subculture	NULL
.	NULL

U937	NULL
cells	NULL
originally	NULL
derived	NULL
from	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
were	NULL
procured	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
grown	NULL
in	NULL
suspension	NULL
culture	NULL
in	NULL
RPMI-1640	NULL
media	NULL
(	NULL
M.A	NULL
.	NULL

Bioproducts	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
FBS	NULL
and	NULL
routinely	NULL
subcultured	NULL
at	NULL
a	NULL
1:5	NULL
ratio	NULL
three	NULL
times	NULL
per	NULL
week	NULL
.	NULL

Separation	NULL
of	NULL
human	NULL
leukocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
separated	NULL
from	NULL
peripheral	NULL
blood	NULL
(	NULL
100	NULL
U/ml	NULL
heparin	NULL
)	NULL
by	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
of	NULL
Recalde	NULL
(	NULL
45	NULL
)	NULL
as	NULL
we	NULL
have	NULL
recently	NULL
described	NULL
in	NULL
detail	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
mononuclear	NULL
cells	NULL
were	NULL
collected	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
(	NULL
47	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
NaCl	NULL
,	NULL
and	NULL
re-isolated	NULL
with	NULL
Ficoll-Hy-paque	NULL
.	NULL

The	NULL
isolated	NULL
monocytes	NULL
were	NULL
resuspended	NULL
in	NULL
MCDB	NULL
107	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
in	NULL
a	NULL
Teflon	NULL
beaker	NULL
to	NULL
prevent	NULL
attachment	NULL
during	NULL
radioactive	NULL
label-ing	NULL
.	NULL

Isolated	NULL
populations	NULL
were	NULL
routinely	NULL
78-90	NULL
%	NULL
monocytes	NULL
by	NULL
differential	NULL
count	NULL
with	NULL
buffered	NULL
Wright-Giemsa	NULL
stain	NULL
,	NULL
and	NULL
viability	NULL
was	NULL
always	NULL
>	NULL
90	NULL
%	NULL
by	NULL
Trypan	NULL
blue	NULL
dye	NULL
exclusion	NULL
.	NULL

Assay	NULL
for	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL

U937	NULL
cell	NULL
monocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
was	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
ECs	NULL
were	NULL
plated	NULL
into	NULL
24-well	NULL
plates	NULL
48	NULL
to	NULL
72	NULL
h	NULL
before	NULL
the	NULL
assay	NULL
.	NULL

In	NULL
nutritional	NULL
experiments	NULL
,	NULL
the	NULL
growth	NULL
medium	NULL
was	NULL
supplemented	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
M	NULL
)	NULL
.	NULL

When	NULL
the	NULL
ECs	NULL
were	NULL
confluent	NULL
,	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
to	NULL
MCDB	NULL
107	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
for	NULL
the	NULL
given	NULL
pretreatment	NULL
time	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
the	NULL
concentration	NULL
of	NULL
FBS	NULL
in	NULL
the	NULL
pretreatment	NULL
media	NULL
was	NULL
varied	NULL
.	NULL

On	NULL
the	NULL
day	NULL
of	NULL
the	NULL
assay	NULL
the	NULL
media	NULL
was	NULL
once	NULL
again	NULL
changed	NULL
and	NULL
additional	NULL
a-tcp	NULL
added	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
the	NULL
various	NULL
agonists	NULL
for	NULL
4	NULL
to	NULL
6	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

U937	NULL
cells	NULL
or	NULL
human	NULL
monocytes	NULL
were	NULL
labeled	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
with	NULL
100	NULL
LCi	NULL
*'Cr	NULL
as	NULL
sodium	NULL
chromate	NULL
(	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
1	NULL
ml	NULL
culture	NULL
media	NULL
.	NULL

The	NULL
labeled	NULL
cells	NULL
were	NULL
washed	NULL
by	NULL
centrifugation	NULL
and	NULL
10°	NULL
viable	NULL
cells	NULL
added	NULL
per	NULL
well	NULL
of	NULL
ECs	NULL
after	NULL
removal	NULL
of	NULL
the	NULL
incubation	NULL
media	NULL
.	NULL

This	NULL
binding	NULL
phase	NULL
of	NULL
the	NULL
assay	NULL
was	NULL
performed	NULL
at	NULL
4°C	NULL
for	NULL
1	NULL
h	NULL
,	NULL
then	NULL
the	NULL
wells	NULL
were	NULL
washed	NULL
and	NULL
the	NULL
cells	NULL
lysed	NULL
with	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
an	NULL
aliquot	NULL
removed	NULL
for	NULL
quantitation	NULL
of	NULL
radiolabel	NULL
.	NULL

The	NULL
number	NULL
of	NULL
U937	NULL
cells	NULL
or	NULL
monocytes	NULL
bound	NULL
per	NULL
well	NULL
was	NULL
calculated	NULL
from	NULL
the	NULL
initial	NULL
specific	NULL
activity	NULL
(	NULL
¢pm/cell	NULL
)	NULL
.	NULL

Spontaneous	NULL
release	NULL
of	NULL
*'Cr	NULL
from	NULL
the	NULL
monocytic	NULL
cells	NULL
during	NULL
the	NULL
assay	NULL
incubation	NULL
was	NULL
<	NULL
5	NULL
%	NULL
.	NULL

All	NULL
presented	NULL
data	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
three	NULL
experiments	NULL
with	NULL
determinations	NULL
made	NULL
in	NULL
triplicate	NULL
.	NULL

Protein	NULL
synthesis	NULL
by	NULL
ECs	NULL
.	NULL

Protein	NULL
synthesis	NULL
by	NULL
the	NULL
ECs	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
incorporation	NULL
of	NULL
[	NULL
*H	NULL
]	NULL
leucine	NULL
into	NULL
TCA-precipitable	NULL
material	NULL
,	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
EC	NULL
were	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
as	NULL
for	NULL
the	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
assay	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*H	NULL
}	NULL
leucine	NULL
(	NULL
2	NULL
uCi/ml	NULL
)	NULL
.	NULL

The	NULL
cell-associated	NULL
and	NULL
secreted	NULL
protein	NULL
synthesis	NULL
was	NULL
measured	NULL
by	NULL
TCA	NULL
precipitation	NULL
of	NULL
the	NULL
proteins	NULL
,	NULL
solubilization	NULL
of	NULL
the	NULL
membranes	NULL
with	NULL
0.25	NULL
N	NULL
sodium	NULL
hydroxide	NULL
and	NULL
determination	NULL
of	NULL
the	NULL
radioactivity	NULL
incorporated	NULL
into	NULL
the	NULL
TCA-precipitable	NULL
material	NULL
.	NULL

Measurement	NULL
of	NULL
E-selectin	NULL
on	NULL
EC	NULL
surface	NULL
.	NULL

E-selectin	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
ECs	NULL
was	NULL
quantified	NULL
using	NULL
an	NULL
anti-E-selectin	NULL
monoclonal	NULL
antibody	NULL
(	NULL
7A9	NULL
)	NULL
(	NULL
50	NULL
)	NULL
,	NULL
as	NULL
we	NULL
have	NULL
previously	NULL
described	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
ECs	NULL
were	NULL
cultured	NULL
in	NULL
48-well	NULL
plates	NULL
for	NULL
48	NULL
h.	NULL
At	NULL
confluence	NULL
,	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
to	NULL
MCDB	NULL
107	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
with	NULL
or	NULL
without	NULL
a-tcp	NULL
for	NULL
72	NULL
h.	NULL
On	NULL
the	NULL
day	NULL
of	NULL
the	NULL
assay	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
once	NULL
again	NULL
and	NULL
new	NULL
a-tep	NULL
added	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Following	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
MCDB	NULL
107	NULL
media	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

The	NULL
primary	NULL
monoclonal	NULL
antibody	NULL
7A9	NULL
and	NULL
secondary	NULL
biotin-conjugated	NULL
affinity-purified	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
;	NULL
fragment	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
+	NULL
IgM	NULL
(	NULL
Jackson	NULL
Immuno	NULL
Research	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
were	NULL
prepared	NULL
in	NULL
wash	NULL
media	NULL
(	NULL
1	NULL
%	NULL
BSA	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
in	NULL
a	NULL
sequential	NULL
manner	NULL
for	NULL
30	NULL
min	NULL
each	NULL
,	NULL
followed	NULL
by	NULL
'	NULL
``	NULL
I-streptavidin	NULL
(	NULL
5	NULL
Ci/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

All	NULL
incubations	NULL
were	NULL
performed	NULL
at	NULL
4°C	NULL
with	NULL
the	NULL
wells	NULL
being	NULL
washed	NULL
3-4	NULL
times	NULL
between	NULL
each	NULL
incubation	NULL
.	NULL

ECs	NULL
were	NULL
lysed	NULL
with	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
an	NULL
aliquot	NULL
removed	NULL
for	NULL
radiolabel	NULL
quantitation	NULL
.	NULL

A	NULL
nonspecific	NULL
isotype	NULL
control	NULL
protein	NULL
MOPC	NULL
21	NULL
(	NULL
a	NULL
mouse	NULL
myeloma	NULL
IgG1	NULL
--	NULL
protein	NULL
)	NULL
,	NULL
was	NULL
included	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
to	NULL
ascertain	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
monoclonal	NULL
antibody	NULL
.	NULL

Northern	NULL
analysis	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
EC	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
15-cm-diameter	NULL
plates	NULL
with	NULL
MCDB	NULL
107	NULL
containing	NULL
15	NULL
%	NULL
FBS	NULL
,	NULL
90	NULL
mg/ml	NULL
heparin	NULL
and	NULL
150	NULL
mg/ml	NULL
ECGS	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
.	NULL

Once	NULL
confluent	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
fresh	NULL
media	NULL
(	NULL
MCDB	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
)	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
.	NULL

On	NULL
the	NULL
day	NULL
of	NULL
the	NULL
experi-ment	NULL
,	NULL
the	NULL
medium	NULL
was	NULL
changed	NULL
again	NULL
and	NULL
the	NULL
monolayers	NULL
treated	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
or	NULL
media	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Steady-state	NULL
mRNA	NULL
levels	NULL
were	NULL
determined	NULL
by	NULL
northern	NULL
analysis	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
51	NULL
)	NULL
.	NULL

The	NULL
conditioned	NULL
medium	NULL
was	NULL
then	NULL
aspirated	NULL
;	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
;	NULL
and	NULL
the	NULL
total	NULL
RNA	NULL
extracted	NULL
with	NULL
guanidinium	NULL
isothiocyanate	NULL
.	NULL

RNA	NULL
was	NULL
obtained	NULL
by	NULL
isopycnic	NULL
centrifugation	NULL
over	NULL
CsCl	NULL
(	NULL
52	NULL
)	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
formaldehyde	NULL
denaturing	NULL
gel	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
to	NULL
a	NULL
Nytran	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
membrane	NULL
by	NULL
capillary	NULL
transfer	NULL
,	NULL
UV	NULL
crosslinked	NULL
,	NULL
prehybridized	NULL
at	NULL
42°C	NULL
for	NULL
a	NULL
minimum	NULL
of	NULL
6	NULL
h	NULL
and	NULL
hybridized	NULL
overnight	NULL
at	NULL
42°C	NULL
with	NULL
P-dCTP	NULL
random	NULL
primer-labeled	NULL
cDNA	NULL
probe	NULL
for	NULL
E-selectin	NULL
(	NULL
1.85	NULL
kb	NULL
cDNA	NULL
in	NULL
pCDN	NULL
[	NULL
amp	NULL
'	NULL
]	NULL
)	NULL
or	NULL
a	NULL
°P-dCTP	NULL
kinase-labeled	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
the	NULL
18	NULL
S	NULL
ribosomal	NULL
RNA	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
then	NULL
washed	NULL
until	NULL
the	NULL
background	NULL
counts	NULL
were	NULL
insignificant	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
at	NULL
-70°C	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

The	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
NFkB	NULL
DNA	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
,	NULL
GGGGATTTCC	NULL
was	NULL
synthesized	NULL
using	NULL
an	NULL
Applied	NULL
Biosystems	NULL
380B	NULL
DNA	NULL
Synthesizer	NULL
and	NULL
purified	NULL
by	NULL
gel	NULL
filtration	NULL
through	NULL
a	NULL
Sephadex	NULL
G-25	NULL
column	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
28-residue	NULL
oligonucleotide	NULL
was	NULL
taken	NULL
from	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
(	NULL
5-AGGCCATT-GGGGATTTCCTCT-TTACTGG-3	NULL
'	NULL
)	NULL
(	NULL
53	NULL
)	NULL
.	NULL

(	NULL
The	NULL
underlined	NULL
sequence	NULL
represents	NULL
the	NULL
consensus	NULL
B	NULL
region	NULL
.	NULL
)	NULL

In	NULL
competition	NULL
studies	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
TF-IIIC	NULL
consensus	NULL
sequence	NULL
(	NULL
-5'-CCGGATCCGGGGTTC-GAACCCCGGCCCAA-3	NULL
'	NULL
)	NULL
was	NULL
used	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
annealed	NULL
and	NULL
labeled	NULL
by	NULL
a	NULL
``	NULL
'filling-in	NULL
``	NULL
reaction	NULL
,	NULL
using	NULL
a-	NULL
[	NULL
``	NULL
°P	NULL
]	NULL
-dCTP	NULL
,	NULL
unlabeled	NULL
dTTP	NULL
and	NULL
the	NULL
Kienow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
modified	NULL
procedure	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
55	NULL
)	NULL
.	NULL

After	NULL
72	NULL
h	NULL
of	NULL
pretreatment	NULL
with	NULL
a-tep	NULL
(	NULL
90	NULL
uM	NULL
)	NULL
,	NULL
EC	NULL
were	NULL
treated	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
fresh	NULL
a-top	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
scraped	NULL
and	NULL
harvested	NULL
by	NULL
centrifugation	NULL
.	NULL

Cells	NULL
were	NULL
resuspended	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
hypotonic	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
antipain	NULL
)	NULL
and	NULL
then	NULL
vortexed	NULL
for	NULL
10	NULL
s	NULL
with	NULL
0.6	NULL
%	NULL
NP-40	NULL
.	NULL

Nuclei	NULL
were	NULL
separated	NULL
from	NULL
the	NULL
cytosol	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
g	NULL
for	NULL
60	NULL
s	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.4	NULL
M	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
Vitamin	NULL
E	NULL
Inhibits	NULL
Induced	NULL
Monocyte	NULL
Adhesion	NULL
to	NULL
Endothelium	NULL
593	NULL
\	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
10	NULL
ug/ml	NULL
each	NULL
of	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
antipain	NULL
)	NULL
and	NULL
shaken	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
obtained	NULL
by	NULL
centrifugation	NULL
at	NULL
12,000	NULL
g	NULL
and	NULL
dia-lyzed	NULL
against	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
Tris-Cl	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.1	NULL
M	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
)	NULL
,	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio	NULL
Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
binding	NULL
reactions	NULL
,	NULL
nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
15-25	NULL
pl	NULL
of	NULL
total	NULL
reaction	NULL
volume	NULL
,	NULL
containing	NULL
20	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
60	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
8	NULL
%	NULL
glycerol	NULL
and	NULL
2.0	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
Fine	NULL
Chemicals	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
radiolabeled	NULL
oligonucleotide	NULL
(	NULL
40,000-50,000	NULL
cpm	NULL
)	NULL
,	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
competition	NULL
analysis	NULL
studies	NULL
,	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
or	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
(	NULL
TF	NULL
HIC	NULL
)	NULL
was	NULL
coincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
for	NULL
15	NULL
min	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
with	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

Samples	NULL
were	NULL
loaded	NULL
on	NULL
non-denaturing	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
low-ionic-strength	NULL
buffer	NULL
(	NULL
22.3	NULL
mM	NULL
Tris	NULL
,	NULL
22.2	NULL
mM	NULL
borate	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
electrophoresis	NULL
performed	NULL
at	NULL
15	NULL
V/cm	NULL
with	NULL
cooling	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
then	NULL
dried	NULL
and	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

Protein	NULL
phosphorylation	NULL
in	NULL
ECs	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
a-tcp	NULL
on	NULL
PKC	NULL
,	NULL
protein	NULL
phosphorylation	NULL
assays	NULL
were	NULL
conducted	NULL
using	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Rozengurt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
56	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
EC	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
21-cm*	NULL
cell	NULL
culture	NULL
dishes	NULL
coated	NULL
with	NULL
fibronectin	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Once	NULL
confluent	NULL
,	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
to	NULL
MCDB	NULL
107	NULL
containing	NULL
5	NULL
%	NULL
FBS	NULL
,	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
,	NULL
for	NULL
72	NULL
h.	NULL
All	NULL
experiments	NULL
were	NULL
done	NULL
in	NULL
duplicate	NULL
dishes	NULL
.	NULL

On	NULL
the	NULL
day	NULL
of	NULL
the	NULL
assay	NULL
the	NULL
EC	NULL
were	NULL
metabolically	NULL
labeled	NULL
using	NULL
*P-orthophosphate	NULL
(	NULL
200	NULL
uCi/ml	NULL
)	NULL
(	NULL
ICN	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
in	NULL
phosphate-free	NULL
media	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
(	NULL
45	NULL
pM	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Half	NULL
an	NULL
hour	NULL
prior	NULL
to	NULL
stimulation	NULL
,	NULL
some	NULL
plates	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
PKC	NULL
inhibitor	NULL
,	NULL
H-7	NULL
(	NULL
100	NULL
M	NULL
)	NULL
(	NULL
Seikagaku	NULL
America	NULL
,	NULL
Inc.	NULL
,	NULL
St.	NULL
Petersburg	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
,	NULL
which	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
or	NULL
IL-1/3	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
5	NULL
min	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
stopped	NULL
by	NULL
removing	NULL
the	NULL
incubation	NULL
media	NULL
and	NULL
washing	NULL
three	NULL
times	NULL
with	NULL
ice	NULL
cold	NULL
PBS	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
two	NULL
10-min	NULL
10	NULL
%	NULL
TCA	NULL
washes	NULL
and	NULL
three	NULL
subsequent	NULL
PBS	NULL
washes	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
TCA-insoluble	NULL
material	NULL
was	NULL
solubilized	NULL
with	NULL
0.25	NULL
ml	NULL
of	NULL
1	NULL
%	NULL
NP-40	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
in	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
10	NULL
mM	NULL
NaCl	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
MgCl	NULL
;	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
microcentrifuged	NULL
(	NULL
14,000	NULL
rpm	NULL
for	NULL
15	NULL
min	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
containing	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
was	NULL
transferred	NULL
to	NULL
another	NULL
microcentrifuge	NULL
tube	NULL
,	NULL
50	NULL
l	NULL
of	NULL
5	NULL
%	NULL
Laemmli	NULL
buffer	NULL
added	NULL
and	NULL
the	NULL
mixture	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
before	NULL
separation	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
using	NULL
a	NULL
10	NULL
%	NULL
gel	NULL
as	NULL
described	NULL
by	NULL
Laemmli	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
at	NULL
-70°C	NULL
.	NULL

Reagents	NULL
.	NULL

Purified	NULL
human	NULL
monocyte	NULL
IL-13	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Otsuka	NULL
America	NULL
Pharmaceutical	NULL
Co.	NULL
,	NULL
Ltd.	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Bovine	NULL
a-thrombin	NULL
was	NULL
obtained	NULL
from	NULL
U.S.	NULL
Biochemical	NULL
Corp	NULL
(	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
7A9	NULL
against	NULL
E-selectin	NULL
and	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
E-selectin	NULL
were	NULL
generous	NULL
gifts	NULL
of	NULL
Dr.	NULL
W.	NULL
Newman	NULL
(	NULL
Otsuka	NULL
America	NULL
,	NULL
Rock-ville	NULL
,	NULL
MD	NULL
)	NULL
(	NULL
50	NULL
)	NULL
.	NULL

Probucol	NULL
was	NULL
supplied	NULL
by	NULL
Marrion	NULL
Merrell	NULL
Dow	NULL
Pharmaceuticals	NULL
(	NULL
Kansas	NULL
City	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

N	NULL
,	NULL
N-diphenyl-1,4-phenylene	NULL
diamine	NULL
(	NULL
DPPD	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Aldrich	NULL
Chemical	NULL
Company	NULL
,	NULL
Inc.	NULL
(	NULL
Milwau-kee	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Desferal	NULL
was	NULL
obtained	NULL
from	NULL
Ciba-Geigy	NULL
(	NULL
Summit	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Ascorbic	NULL
acid	NULL
,	NULL
butylated	NULL
hydroxytoluene	NULL
(	NULL
BHT	NULL
)	NULL
,	NULL
tocopherol	NULL
acetate	NULL
and	NULL
dl-a-tep	NULL
,	NULL
heparin	NULL
,	NULL
LPS	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
all	NULL
media	NULL
components	NULL
not	NULL
previously	NULL
mentioned	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
.	NULL

Results	NULL
a-tcp	NULL
inhibits	NULL
IL-1-induced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
.	NULL

a	NULL
«	NULL
-tep	NULL
inhibited	NULL
IL-1	NULL
-induced	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
ECs	NULL
in	NULL
a	NULL
time-	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
concentration-	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
dependent	NULL
manner	NULL
.	NULL

The	NULL
ICs	NULL
,	NULL
for	NULL
a-tep	NULL
was	NULL
45	NULL
uM	NULL
,	NULL
a	NULL
physiologically	NULL
relevant	NULL
concentration	NULL
since	NULL
plasma	NULL
levels	NULL
of	NULL
this	NULL
vitamin	NULL
are	NULL
normally	NULL
in	NULL
the	NULL
range	NULL
of	NULL
20-35	NULL
uM	NULL
(	NULL
58	NULL
)	NULL
.	NULL

The	NULL
optimal	NULL
pretreatment	NULL
time	NULL
for	NULL
the	NULL
inhibitory	NULL
effect	NULL
was	NULL
~	NULL
72	NULL
h.	NULL
Unstimulated	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
to	NULL
ECs	NULL
was	NULL
negligible	NULL
and	NULL
unaffected	NULL
by	NULL
a-tcp	NULL
pretreatment	NULL
of	NULL
594	NULL
Faruqi	NULL
et	NULL
al	NULL
.	NULL

2	NULL
2.5	NULL
~	NULL
0	NULL
2	NULL
w	NULL
*~	NULL
p	NULL
a	NULL
x	NULL
2	NULL
had	NULL
©	NULL
k-	NULL
]	NULL
b	NULL
C	NULL
c	NULL
€	NULL
115	NULL
G	NULL
a	NULL
3	NULL
a	NULL
a	NULL
|	NULL
!	NULL

x	NULL
09	NULL
wh	NULL
2	NULL
1	NULL
8	NULL
$	NULL
8	NULL
-	NULL
$	NULL
I	NULL
3	NULL
&	NULL
0.5	NULL
3	NULL
-	NULL
b	NULL
0	NULL
0	NULL
000	NULL
120	NULL
24	NULL
360	NULL
480	NULL
600	NULL
720	NULL
s4	NULL
96	NULL
Pretreatment	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
pretreatment	NULL
time	NULL
with	NULL
a-tcp	NULL
on	NULL
IL-1	NULL
-induced	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
(	NULL
C	NULL
)	NULL
and	NULL
protein	NULL
synthesis	NULL
(	NULL
[	NULL
*°H	NULL
[	NULL
leucine	NULL
incorporation	NULL
)	NULL
by	NULL
(	NULL
0	NULL
)	NULL
ECs	NULL
.	NULL

ECs	NULL
were	NULL
pretreated	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
for	NULL
varying	NULL
time	NULL
periods	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
4	NULL
h.	NULL
Error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

the	NULL
ECs	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
IL-1-induced	NULL
monocytic	NULL
cell	NULL
binding	NULL
to	NULL
ECs	NULL
varied	NULL
in	NULL
different	NULL
EC	NULL
isolates	NULL
and	NULL
ranged	NULL
from	NULL
30-70	NULL
%	NULL
inhibition	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
45	NULL
wM	NULL
a-tep	NULL
.	NULL

Protein	NULL
synthesis	NULL
by	NULL
the	NULL
ECs	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
[	NULL
*H	NULL
]	NULL
leucine	NULL
incorporation	NULL
into	NULL
TCA-precipitable	NULL
material	NULL
,	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
the	NULL
tcp	NULL
pretreatment	NULL
,	NULL
except	NULL
for	NULL
a	NULL
slight	NULL
reduction	NULL
at	NULL
the	NULL
highest	NULL
concentrations	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-1	NULL
-induced	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
was	NULL
confirmed	NULL
using	NULL
freshly	NULL
isolated	NULL
blood	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
multiple	NULL
experiments	NULL
with	NULL
normal	NULL
monocytes	NULL
a-tcp-induced	NULL
inhibition	NULL
of	NULL
adhesion	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
U937	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
a-tep	NULL
was	NULL
specific	NULL
for	NULL
IL-1-induced	NULL
adhesion	NULL
,	NULL
we	NULL
tested	NULL
a	NULL
series	NULL
of	NULL
agonists	NULL
for	NULL
the	NULL
sensitivity	NULL
of	NULL
their	NULL
stimulation	NULL
to	NULL
a-tep	NULL
.	NULL

ECs	NULL
were	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
10	NULL
nM	NULL
)	NULL
,	NULL
and	NULL
a-thrombin	NULL
(	NULL
30	NULL
U/ml	NULL
)	NULL
,	NULL
for	NULL
4	NULL
to	NULL
6	NULL
h	NULL
after	NULL
72	NULL
h	NULL
pretreatment	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
M	NULL
)	NULL
.	NULL

In	NULL
every	NULL
case	NULL
a-tcp	NULL
significantly	NULL
abrogated	NULL
the	NULL
agonist-induced	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

1	NULL
2	NULL
~	NULL
&	NULL
i	NULL
:	NULL
x	NULL
2	NULL
5	NULL
Ag	NULL
.	NULL

E	NULL
$	NULL
:	NULL
a	NULL
13—	NULL
.	NULL

3	NULL
3	NULL
0.5	NULL
18	NULL
&	NULL
3	NULL
9	NULL
%	NULL
8	NULL
~	NULL
$	NULL
D	NULL
2	NULL
w	NULL
3	NULL
``	NULL
2	NULL
3	NULL
2	NULL
0	NULL
0	NULL
0	NULL
0.1	NULL
10	NULL
1000	NULL
Alpha-tocopherol	NULL
(	NULL
LM	NULL
)	NULL
Figure	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
«	NULL
-top	NULL
on	NULL
IL-1	NULL
-induced	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
(	NULL
C	NULL
)	NULL
and	NULL
protein	NULL
synthesis	NULL
incorporation	NULL
)	NULL
by	NULL
(	NULL
0	NULL
)	NULL
ECs	NULL
.	NULL

ECs	NULL
were	NULL
treated	NULL
with	NULL
a-tep	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
4	NULL
h.	NULL
I	NULL
I	NULL
~	NULL
[	NULL
-	NULL
]	NULL
o	NULL
»	NULL
r	NULL
B	NULL
|	NULL
3	NULL
o	NULL
g	NULL
o.s	NULL
g	NULL
\	NULL
a	NULL
0	NULL
f3	NULL
&	NULL
0	NULL
\	NULL
<	NULL
:	NULL
\	NULL
«	NULL
0	NULL
b	NULL
INN	NULL
0	NULL
4	NULL
5	NULL
180	NULL
Alpha-tocopherol	NULL
(	NULL
LM	NULL
)	NULL
Figure	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
«	NULL
-tcp	NULL
on	NULL
IL-1	NULL
-induced	NULL
peripheral	NULL
blood	NULL
monocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
.	NULL

Experimental	NULL
conditions	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
described	NULL
for	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
0	NULL
)	NULL
Basal	NULL
monocyte	NULL
binding	NULL
;	NULL
(	NULL
®	NULL
)	NULL
IL-1	NULL
-stimulated	NULL
monocyte	NULL
binding	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

To	NULL
this	NULL
point	NULL
we	NULL
had	NULL
used	NULL
a-tep	NULL
as	NULL
a	NULL
pharmacological	NULL
agent	NULL
,	NULL
pretreating	NULL
the	NULL
ECs	NULL
only	NULL
after	NULL
they	NULL
had	NULL
reached	NULL
confluence	NULL
.	NULL

To	NULL
study	NULL
the	NULL
effect	NULL
of	NULL
a-tcp	NULL
when	NULL
used	NULL
as	NULL
a	NULL
growth	NULL
supplement	NULL
,	NULL
ECs	NULL
were	NULL
grown	NULL
to	NULL
confluence	NULL
in	NULL
growth	NULL
media	NULL
(	NULL
MCDB	NULL
107	NULL
+	NULL
Heparin	NULL
+	NULL
ECGS	NULL
+	NULL
15	NULL
%	NULL
FBS	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
«	NULL
-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
.	NULL

Upon	NULL
reaching	NULL
confluence	NULL
(	NULL
usually	NULL
within	NULL
3	NULL
d	NULL
)	NULL
,	NULL
the	NULL
media	NULL
was	NULL
changed	NULL
to	NULL
the	NULL
pretreatment	NULL
media	NULL
(	NULL
MCDB	NULL
107	NULL
+	NULL
5	NULL
%	NULL
FBS	NULL
and	NULL
no	NULL
growth	NULL
supplements	NULL
)	NULL
,	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
,	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
.	NULL

ECs	NULL
grown	NULL
with	NULL
supplemental	NULL
a-tcp	NULL
bound	NULL
significantly	NULL
less	NULL
monocytic	NULL
cells	NULL
when	NULL
stimulated	NULL
with	NULL
IL-1	NULL
as	NULL
compared	NULL
with	NULL
ECs	NULL
that	NULL
had	NULL
not	NULL
3	NULL
Expt	NULL
.	NULL

1	NULL
Expt	NULL
.	NULL

2	NULL
Expt	NULL
.	NULL

3	NULL
Expt	NULL
.	NULL

4	NULL
(	NULL
-	NULL
]	NULL
b=	NULL
K	NULL
G	NULL
2	NULL
&	NULL
=	NULL
0	NULL
A	NULL
&	NULL
$	NULL
8	NULL
4	NULL
Ie	NULL
&	NULL
[	NULL
-	NULL
)	NULL
a=	NULL
)	NULL
o	NULL
--	NULL
-	NULL
corm	NULL
COz	NULL
Cta	NULL
r—LZ	NULL
!	NULL

E4	NULL
r-	NULL
E4	NULL
Lsd	NULL
€	NULL
im	NULL
]	NULL
Ej	NULL
C	NULL
m	NULL
&	NULL
m	NULL
``	NULL
0	NULL
m	NULL
I	NULL
m	NULL
&	NULL
9	NULL
t	NULL
Og	NULL
0	NULL
9	NULL
0	NULL
Og	NULL
-	NULL
=	NULL
-	NULL
y	NULL
=	NULL
>	NULL
bd	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
Agonist	NULL
Figure	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
«	NULL
-top	NULL
pretreatment	NULL
on	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
ECs	NULL
in	NULL
response	NULL
to	NULL
multiple	NULL
agonists	NULL
of	NULL
monocyte	NULL
adhesion	NULL
.	NULL

ECs	NULL
were	NULL
pretreated	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
the	NULL
different	NULL
agonists	NULL
for	NULL
4-6	NULL
h.	NULL
Each	NULL
section	NULL
represents	NULL
different	NULL
experiments	NULL
,	NULL
since	NULL
the	NULL
responsiveness	NULL
of	NULL
the	NULL
ECs	NULL
varied	NULL
depending	NULL
on	NULL
isolate	NULL
,	NULL
passage	NULL
number	NULL
and	NULL
agonist	NULL
used	NULL
.	NULL

(	NULL
G	NULL
)	NULL
ECs	NULL
that	NULL
were	NULL
not	NULL
pretreated	NULL
with	NULL
a-tcp	NULL
,	NULL
and	NULL
(	NULL
@	NULL
)	NULL
those	NULL
that	NULL
were	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

1.5	NULL
~	NULL
I	NULL
&	NULL
x	NULL
;	NULL
1.01	NULL
\	NULL
£	NULL
3	NULL
8	NULL
1	NULL
2	NULL
a	NULL
8	NULL
-	NULL
0.57	NULL
is	NULL
g	NULL
I	NULL
§	NULL
.	NULL

_	NULL
RY	NULL
Med/Med	NULL
Tep/Med	NULL
Med/Tep	NULL
Tep/Tep	NULL
Growth/pretreatment	NULL
condition	NULL
Figure	NULL
5	NULL
.	NULL

Effect	NULL
of	NULL
a-tep	NULL
as	NULL
a	NULL
growth	NULL
supplement	NULL
on	NULL
IL-1	NULL
-induced	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
ECs	NULL
.	NULL

ECs	NULL
were	NULL
grown	NULL
in	NULL
media	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
as	NULL
a	NULL
growth	NULL
supplement	NULL
.	NULL

Once	NULL
confluent	NULL
,	NULL
ECs	NULL
were	NULL
pretreated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
or	NULL
without	NULL
a-tcp	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
for	NULL
4	NULL
h.	NULL
(	NULL
0	NULL
)	NULL
Basal	NULL
;	NULL
(	NULL
@	NULL
)	NULL
IL-1-stimulated	NULL
U937	NULL
cell	NULL
binding	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

been	NULL
exposed	NULL
to	NULL
the	NULL
vitamin	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
was	NULL
true	NULL
even	NULL
if	NULL
no	NULL
a-tcp	NULL
was	NULL
added	NULL
during	NULL
the	NULL
pretreatment	NULL
phase	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

The	NULL
most	NULL
marked	NULL
decrease	NULL
in	NULL
monocytic	NULL
cell	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
ECs	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
a-tcp	NULL
both	NULL
in	NULL
the	NULL
``	NULL
growth	NULL
``	NULL
and	NULL
``	NULL
pretreatment	NULL
``	NULL
phase	NULL
of	NULL
the	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Neither	NULL
the	NULL
basal	NULL
level	NULL
of	NULL
binding	NULL
nor	NULL
protein	NULL
synthesis	NULL
was	NULL
affected	NULL
by	NULL
a-tcp	NULL
in	NULL
either	NULL
phase	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
a	NULL
«	NULL
-tcp	NULL
on	NULL
EC	NULL
expression	NULL
of	NULL
E-selectin	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
E-selectin	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
cultured	NULL
ECs	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

We	NULL
have	NULL
verified	NULL
this	NULL
in	NULL
our	NULL
system	NULL
by	NULL
demonstrating	NULL
the	NULL
ability	NULL
of	NULL
an	NULL
anti-E-selectin	NULL
monoclonal	NULL
antibody	NULL
to	NULL
dramatically	NULL
inhibit	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
IL-l-treated	NULL
EC	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a-tcp	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effect	NULL
of	NULL
a-top	NULL
on	NULL
E-selectin	NULL
expression	NULL
,	NULL
we	NULL
quantified	NULL
this	NULL
glycoprotein	NULL
on	NULL
the	NULL
EC	NULL
surface	NULL
using	NULL
a	NULL
mono	NULL
IL-1	NULL
Alpha-tocopherol	NULL
+	NULL
IL-1	NULL
[	NULL
U	NULL
Figure	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
7A9	NULL
)	NULL
to	NULL
E-selectin	NULL
on	NULL
U937	NULL
cell	NULL
adhesion	NULL
to	NULL
IL-1	NULL
-stimulated	NULL
ECs	NULL
.	NULL

ECs	NULL
were	NULL
pretreated	NULL
with	NULL
or	NULL
without	NULL
a-tep	NULL
(	NULL
45	NULL
M	NULL
)	NULL
for	NULL
48	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
cells	NULL
were	NULL
rinsed	NULL
and	NULL
incubated	NULL
with	NULL
media	NULL
,	NULL
MOPC-21	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
or	NULL
mAb	NULL
7A9	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
before	NULL
the	NULL
U937	NULL
cell	NULL
binding	NULL
assay	NULL
was	NULL
performed	NULL
.	NULL

|	NULL
U937	NULL
Cells	NULL
Bound	NULL
(	NULL
x10	NULL
'	NULL
)	NULL
MmMoPC	NULL
media	NULL
MoPC	NULL
Mab	NULL
7A9	NULL
Q	NULL
Mab	NULL
7A9	NULL
Vitamin	NULL
E	NULL
Inhibits	NULL
Induced	NULL
Monocyte	NULL
Adhesion	NULL
to	NULL
Endothelium	NULL
595	NULL
A	NULL
<	NULL
3	NULL
o	NULL
x	NULL
e	NULL
3	NULL
o	NULL
Kel	NULL
A	NULL
o	NULL
C	NULL
``	NULL
3	NULL
m	NULL
&	NULL
&	NULL
2	NULL
0	NULL
(	NULL
e	NULL
0	NULL
1	NULL
0	NULL
£5	NULL
-	NULL
!	NULL

£5	NULL
©	NULL
£	NULL
o	NULL
4	NULL
+0	NULL
+0	NULL
o	NULL
o	NULL
2	NULL
2	NULL
B	NULL
aA	NULL
20000	NULL
€	NULL
a	NULL
.	NULL

&	NULL
C	NULL
2	NULL
15000	NULL
-3	NULL
0	NULL
m	NULL
C	NULL
5	NULL
10000	NULL
>	NULL
T2	NULL
a	NULL
.	NULL

$	NULL
5000	NULL
i	NULL
us	NULL
~	NULL
al	NULL
.	NULL

a	NULL
ma	NULL
r	NULL
0	NULL
.S	NULL
``	NULL
1	NULL
%	NULL
2	NULL
.	NULL

.	NULL

4	NULL
0	NULL
.5	NULL
1	NULL
2-4	NULL
ies	NULL
media	NULL
ialpha-tocopherol	NULL
Time	NULL
of	NULL
IL-1	NULL
Treatment	NULL
(	NULL
h	NULL
)	NULL
Figure	NULL
7	NULL
.	NULL

Effect	NULL
of	NULL
a	NULL
«	NULL
-tep	NULL
on	NULL
U937	NULL
cell	NULL
adhesion	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
by	NULL
ECs	NULL
.	NULL

ECs	NULL
were	NULL
pretreated	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
LM	NULL
)	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
4	NULL
h	NULL
for	NULL
the	NULL
adhesion	NULL
assay	NULL
and	NULL
as	NULL
shown	NULL
for	NULL
E-selectin	NULL
expression	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
adhesion	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
E-selectin	NULL
surface	NULL
expression	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
monoclonal	NULL
antibody	NULL
(	NULL
7A9	NULL
)	NULL
against	NULL
E-selectin	NULL
,	NULL
a	NULL
biotin-conjugated	NULL
secondary	NULL
antibody	NULL
and	NULL
'	NULL
I-streptavidin	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

clonal	NULL
antibody	NULL
7A9	NULL
in	NULL
a	NULL
sandwich-type	NULL
radioimmunoassay	NULL
.	NULL

Under	NULL
basal	NULL
conditions	NULL
or	NULL
following	NULL
a-tep	NULL
pretreatment	NULL
alone	NULL
,	NULL
EC	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
E-selectin	NULL
.	NULL

IL-1	NULL
stimulation	NULL
of	NULL
the	NULL
ECs	NULL
caused	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
E-selectin	NULL
expression	NULL
which	NULL
was	NULL
significantly	NULL
blunted	NULL
with	NULL
a-tcp	NULL
pretreatment	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
decrease	NULL
in	NULL
E-selectin	NULL
expression	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
inhibition	NULL
of	NULL
agonist-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
by	NULL
a-tcp	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

An	NULL
unrelated	NULL
immunoglobulin	NULL
,	NULL
MOPC	NULL
21	NULL
,	NULL
failed	NULL
to	NULL
show	NULL
a	NULL
corresponding	NULL
increase	NULL
in	NULL
surface	NULL
binding	NULL
,	NULL
indicating	NULL
the	NULL
specificity	NULL
of	NULL
7A9	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
address	NULL
the	NULL
issue	NULL
of	NULL
specificity	NULL
with	NULL
respect	NULL
to	NULL
E-selectin	NULL
we	NULL
have	NULL
assessed	NULL
the	NULL
effect	NULL
of	NULL
a-tep	NULL
on	NULL
induced	NULL
surface	NULL
expression	NULL
of	NULL
ICAM-1	NULL
.	NULL

ICAM-1	NULL
was	NULL
found	NULL
to	NULL
be	NULL
constitutively	NULL
high	NULL
and	NULL
only	NULL
slightly	NULL
induced	NULL
at	NULL
the	NULL
time	NULL
point	NULL
under	NULL
study	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
published	NULL
results	NULL
of	NULL
others	NULL
.	NULL

a-tep	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
this	NULL
induction	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

596	NULL
Farugi	NULL
et	NULL
al	NULL
.	NULL

E-selectin	NULL
18	NULL
S	NULL
RNA	NULL
Pretreatment	NULL
Stimulant	NULL
Figure	NULL
8	NULL
.	NULL

Autoradiograph	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
a-tep	NULL
on	NULL
steady	NULL
state	NULL
message	NULL
for	NULL
E-selectin	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
two	NULL
left	NULL
lanes	NULL
represent	NULL
basal	NULL
E-selectin	NULL
message	NULL
,	NULL
with	NULL
and	NULL
without	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
pretreatment	NULL
,	NULL
while	NULL
the	NULL
two	NULL
right	NULL
lanes	NULL
represent	NULL
IL-1-induced	NULL
E-selectin	NULL
message	NULL
,	NULL
with	NULL
and	NULL
without	NULL
atop	NULL
pretreatment	NULL
(	NULL
72	NULL
h	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
the	NULL
E-selectin	NULL
message	NULL
and	NULL
the	NULL
control	NULL
18	NULL
$	NULL
RNA	NULL
band	NULL
.	NULL

M	NULL
,	NULL
media	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
the	NULL
cytokine-induced	NULL
steady	NULL
state	NULL
mRNA	NULL
levels	NULL
of	NULL
E-selectin	NULL
were	NULL
affected	NULL
by	NULL
a-tcp	NULL
pretreatment	NULL
.	NULL

E-selectin	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
under	NULL
basal	NULL
conditions	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a-top	NULL
.	NULL

IL-1	NULL
stimulation	NULL
of	NULL
ECs	NULL
for	NULL
2	NULL
h	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
induction	NULL
of	NULL
E-selectin	NULL
mRNA	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
significantly	NULL
abrogated	NULL
by	NULL
pretreating	NULL
the	NULL
ECs	NULL
with	NULL
a-tep	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

mRNA	NULL
levels	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
188	NULL
ribosomal	NULL
RNA	NULL
to	NULL
ensure	NULL
equal	NULL
loading	NULL
of	NULL
the	NULL
lanes	NULL
.	NULL

The	NULL
autoradiograph	NULL
was	NULL
subjected	NULL
to	NULL
densitometric	NULL
evaluation	NULL
which	NULL
revealed	NULL
a	NULL
35	NULL
%	NULL
reduction	NULL
in	NULL
E-selectin	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
a-tcp	NULL
.	NULL

This	NULL
decrease	NULL
correlated	NULL
well	NULL
with	NULL
the	NULL
decreased	NULL
expression	NULL
of	NULL
the	NULL
glycoprotein	NULL
and	NULL
decreased	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
agonist-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
to	NULL
ECs	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
a-top	NULL
was	NULL
acting	NULL
by	NULL
its	NULL
free	NULL
radical	NULL
scavenging	NULL
ability	NULL
,	NULL
we	NULL
tested	NULL
other	NULL
known	NULL
antioxidants	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
agonist-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
.	NULL

The	NULL
results	NULL
were	NULL
variable	NULL
;	NULL
while	NULL
some	NULL
of	NULL
the	NULL
antioxidants	NULL
did	NULL
reduce	NULL
induced-adhesion	NULL
,	NULL
others	NULL
did	NULL
not	NULL
(	NULL
Table	NULL
D	NULL
)	NULL
.	NULL

Ascorbic	NULL
acid	NULL
,	NULL
a	NULL
water-soluble	NULL
antioxidant	NULL
,	NULL
in	NULL
fact	NULL
appeared	NULL
to	NULL
further	NULL
stimulate	NULL
induced	NULL
adhesion	NULL
.	NULL

None	NULL
of	NULL
the	NULL
antioxidants	NULL
tested	NULL
had	NULL
any	NULL
significant	NULL
effect	NULL
on	NULL
basal	NULL
levels	NULL
of	NULL
adhesion	NULL
.	NULL

Among	NULL
the	NULL
other	NULL
antioxidants	NULL
tested	NULL
only	NULL
Probucol	NULL
and	NULL
N-acetylcysteine	NULL
(	NULL
NAC	NULL
)	NULL
significantly	NULL
reduced	NULL
IL-1-induced	NULL
adhesion	NULL
.	NULL

Probucol	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
,	NULL
a	NULL
lipid-soluble	NULL
antioxidant	NULL
,	NULL
decreased	NULL
agonist-induced	NULL
adhesion	NULL
by	NULL
45	NULL
%	NULL
;	NULL
at	NULL
higher	NULL
concentrations	NULL
Probucol	NULL
was	NULL
toxic	NULL
to	NULL
ECs	NULL
.	NULL

NAC	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
,	NULL
a	NULL
water-soluble	NULL
antioxidant	NULL
,	NULL
reduced	NULL
IL-1-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
by	NULL
36	NULL
%	NULL
without	NULL
altering	NULL
protein	NULL
synthesis	NULL
.	NULL

Other	NULL
antioxidants	NULL
tested	NULL
,	NULL
such	NULL
as	NULL
DPPD	NULL
,	NULL
Tiron	NULL
,	NULL
and	NULL
Desferal	NULL
,	NULL
failed	NULL
to	NULL
abrogate	NULL
agonist-induced	NULL
adhesion	NULL
at	NULL
nontoxic	NULL
concentrations	NULL
.	NULL

When	NULL
ascorbic	NULL
acid	NULL
and	NULL
a-tep	NULL
were	NULL
used	NULL
together	NULL
,	NULL
no	NULL
net	NULL
effect	NULL
was	NULL
observed	NULL
.	NULL

In	NULL
acting	NULL
as	NULL
a	NULL
free	NULL
radical	NULL
scavenger	NULL
,	NULL
a-tep	NULL
is	NULL
itself	NULL
oxidized	NULL
.	NULL

Since	NULL
we	NULL
pretreated	NULL
ECs	NULL
for	NULL
72	NULL
h	NULL
,	NULL
it	NULL
was	NULL
likely	NULL
that	NULL
oxidation	NULL
products	NULL
of	NULL
a-tep	NULL
accumulated	NULL
in	NULL
the	NULL
microenvironment	NULL
of	NULL
the	NULL
ECs	NULL
during	NULL
this	NULL
time	NULL
.	NULL

We	NULL
explored	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
oxidation	NULL
products	NULL
of	NULL
a-tep	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
inhibitory	NULL
effect	NULL
on	NULL
stimulated	NULL
adhesion	NULL
.	NULL

Copper	NULL
sulfate	NULL
,	NULL
a	NULL
known	NULL
pro-oxidant	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
accelerate	NULL
the	NULL
oxidation	NULL
of	NULL
low	NULL
density	NULL
lipoproteins	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
copper	NULL
sulfate	NULL
with	NULL
a-tep	NULL
would	NULL
presumably	NULL
then	NULL
accelerate	NULL
oxidation	NULL
of	NULL
the	NULL
vitamin	NULL
over	NULL
the	NULL
72	NULL
h	NULL
pretreatment	NULL
period	NULL
.	NULL

While	NULL
copper	NULL
sulfate	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
agonist-induced	NULL
adhesion	NULL
,	NULL
when	NULL
used	NULL
in	NULL
combination	NULL
with	NULL
a-tcp	NULL
,	NULL
it	NULL
diminished	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
Table	NULL
I	NULL
.	NULL

Effect	NULL
of	NULL
Antioxidants	NULL
on	NULL
U937	NULL
Cell	NULL
Adhesion	NULL
to	NULL
ECs	NULL
U937	NULL
Cells	NULL
Bound	NULL
(	NULL
x10	NULL
~*	NULL
)	NULL
*	NULL
Percent	NULL
bound	NULL
compared	NULL
Pretreatment	NULL
Control	NULL
IL-1	NULL
with	NULL
IL-1	NULL
treated	NULL
Experiment	NULL
No	NULL
.	NULL

1	NULL
Media	NULL
0.2	NULL
(	NULL
0.0	NULL
)	NULL
8.1	NULL
(	NULL
0.5	NULL
)	NULL
100	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
0.2	NULL
(	NULL
0.0	NULL
)	NULL
4.0	NULL
(	NULL
0.3	NULL
)	NULL
49	NULL
Experiment	NULL
No	NULL
.	NULL

2	NULL
Media	NULL
0.5	NULL
(	NULL
0.0	NULL
)	NULL
9.1	NULL
(	NULL
1.1	NULL
)	NULL
100	NULL
Ascorbate	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
-	NULL
0.7	NULL
(	NULL
0.0	NULL
)	NULL
-	NULL
13.6	NULL
(	NULL
0.6	NULL
)	NULL
149	NULL
Ascorbate	NULL
+	NULL
a-tep	NULL
_	NULL
0.6	NULL
(	NULL
0.0	NULL
)	NULL
9.0	NULL
(	NULL
0.3	NULL
)	NULL
99	NULL
CuCO	NULL
,	NULL
(	NULL
5	NULL
4M	NULL
)	NULL
0.7	NULL
(	NULL
0.1	NULL
)	NULL
9.2	NULL
(	NULL
1.1	NULL
)	NULL
101	NULL
CuSO	NULL
,	NULL
+	NULL
a-tep	NULL
0.8	NULL
(	NULL
0.0	NULL
)	NULL
74	NULL
(	NULL
0.4	NULL
)	NULL
79	NULL
BHT	NULL
(	NULL
45	NULL
4M	NULL
)	NULL
0.9	NULL
(	NULL
0.1	NULL
)	NULL
9.8	NULL
(	NULL
0.3	NULL
)	NULL
108	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
)	NULL
0.6	NULL
(	NULL
0.0	NULL
)	NULL
5.7	NULL
(	NULL
0.1	NULL
)	NULL
63	NULL
Experiment	NULL
No	NULL
.	NULL

3	NULL
Media	NULL
0.6	NULL
(	NULL
0.1	NULL
)	NULL
9.3	NULL
(	NULL
0.3	NULL
)	NULL
100	NULL
Probucol	NULL
(	NULL
50	NULL
uM	NULL
)	NULL
_	NULL
0.4	NULL
(	NULL
0.0	NULL
)	NULL
5.2	NULL
(	NULL
0.1	NULL
)	NULL
56	NULL
DPPD	NULL
(	NULL
1	NULL
4M	NULL
)	NULL
0.7	NULL
(	NULL
0.1	NULL
)	NULL
9.9	NULL
(	NULL
1.2	NULL
)	NULL
106	NULL
Experiment	NULL
No	NULL
.	NULL

4	NULL
Media	NULL
0.5	NULL
(	NULL
0.1	NULL
)	NULL
_	NULL
42.8	NULL
(	NULL
1.5	NULL
)	NULL
100	NULL
Desferal	NULL
(	NULL
10	NULL
4M	NULL
)	NULL
-	NULL
36.5	NULL
(	NULL
1.6	NULL
)	NULL
85	NULL
Experiment	NULL
No	NULL
.	NULL

5	NULL
Media	NULL
0.5	NULL
(	NULL
0.1	NULL
)	NULL
36.9	NULL
(	NULL
0.9	NULL
)	NULL
100	NULL
Tiron	NULL
(	NULL
100	NULL
aM	NULL
)	NULL
-	NULL
35.9	NULL
(	NULL
1.6	NULL
)	NULL
97	NULL
;	NULL
Experiment	NULL
No	NULL
.	NULL

6	NULL
Media	NULL
0.4	NULL
(	NULL
0.1	NULL
)	NULL
_	NULL
12.8	NULL
(	NULL
0.1	NULL
)	NULL
100	NULL
NAC	NULL
(	NULL
20	NULL
mM	NULL
)	NULL
0.2	NULL
(	NULL
0.0	NULL
)	NULL
8.2	NULL
(	NULL
1.5	NULL
)	NULL
64	NULL
*	NULL
Results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
+SEM	NULL
.	NULL

Experiments	NULL
represent	NULL
one	NULL
of	NULL
three	NULL
similar	NULL
experiments	NULL
.	NULL

latter	NULL
,	NULL
although	NULL
the	NULL
levels	NULL
of	NULL
adhesion	NULL
remained	NULL
lower	NULL
than	NULL
the	NULL
IL-1-stimulated	NULL
control	NULL
levels	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
a-tcp	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Certain	NULL
antioxidants	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
prevent	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
lymphoid	NULL
cells	NULL
(	NULL
20	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
contains	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
this	NULL
transcription	NULL
factor	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
E-selectin	NULL
gene	NULL
transcription	NULL
(	NULL
39	NULL
,	NULL
53	NULL
)	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
PKC	NULL
have	NULL
both	NULL
been	NULL
reported	NULL
to	NULL
activate	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
a-tep	NULL
could	NULL
potentially	NULL
affect	NULL
the	NULL
activity	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
,	NULL
either	NULL
directly	NULL
by	NULL
its	NULL
free	NULL
radical	NULL
scavenging	NULL
property	NULL
or	NULL
indirectly	NULL
by	NULL
inhibiting	NULL
PKC	NULL
.	NULL

We	NULL
used	NULL
EMSAs	NULL
to	NULL
determine	NULL
whether	NULL
a-tcp	NULL
was	NULL
inhibiting	NULL
agonist-induced	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
in	NULL
EC	NULL
by	NULL
blocking	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

ECs	NULL
stimulated	NULL
with	NULL
IL-1	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
1	NULL
h	NULL
contained	NULL
nuclear	NULL
proteins	NULL
corresponding	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Pretreatment	NULL
of	NULL
the	NULL
ECs	NULL
with	NULL
a-top	NULL
for	NULL
72	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
IL-1	NULL
failed	NULL
to	NULL
demonstrate	NULL
a	NULL
decrease	NULL
in	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
labeled	NULL
NF-kB	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Gel	NULL
shift	NULL
bands	NULL
corresponding	NULL
to	NULL
NF-kB	NULL
were	NULL
not	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
ECs	NULL
nor	NULL
did	NULL
a-tep	NULL
pretreatment	NULL
of	NULL
the	NULL
EC	NULL
's	NULL
induce	NULL
the	NULL
appearance	NULL
of	NULL
this	NULL
band	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
was	NULL
verified	NULL
by	NULL
competition	NULL
analysis	NULL
studies	NULL
.	NULL

Coincubating	NULL
the	NULL
ECs	NULL
nuclear	NULL
extracts	NULL
with	NULL
a	NULL
hundred	NULL
fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
,	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
,	NULL
caused	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
gel	NULL
shift	NULL
band	NULL
observed	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-1-stimulated	NULL
ECs	NULL
.	NULL

Competitor	NULL
3	NULL
-	NULL
x	NULL
w	NULL
3	NULL
2	NULL
.	NULL

%	NULL
6	NULL
a	NULL
4	NULL
'	NULL
a	NULL
.	NULL

%	NULL
e	NULL
-_	NULL
L	NULL
C	NULL
«	NULL
{	NULL
«	NULL
2	NULL
&	NULL
L	NULL
-L	NULL
-	NULL
%	NULL
a	NULL
$	NULL
85	NULL
5k	NULL
b	NULL
iE	NULL
§	NULL
|	NULL
g	NULL
--	NULL
NF-x8	NULL
min-3m	NULL
“	NULL
%	NULL
Unbound	NULL
labeled	NULL
Oligonucleotide	NULL
Figure	NULL
9	NULL
.	NULL

Autoradiograph	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
a-tep	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
ECs	NULL
as	NULL
measured	NULL
by	NULL
electromobility	NULL
shift	NULL
assay	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
control	NULL
ECs	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
IL-1	NULL
-treated	NULL
ECs	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
ECs	NULL
pretreated	NULL
with	NULL
a-tep	NULL
(	NULL
45	NULL
uM	NULL
for	NULL
72	NULL
h	NULL
)	NULL
;	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
IL-1-stimulated	NULL
ECs	NULL
that	NULL
have	NULL
been	NULL
pretreated	NULL
with	NULL
a-tcp	NULL
(	NULL
45	NULL
uM	NULL
for	NULL
72	NULL
h	NULL
)	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligomer	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
;	NULL
lane	NULL
8	NULL
,	NULL
100-fold	NULL
excess	NULL
of	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
(	NULL
TFIIIC	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
prior	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Similar	NULL
coincubation	NULL
with	NULL
an	NULL
unrelated	NULL
oligonucleotide	NULL
,	NULL
TF	NULL
IIIC	NULL
,	NULL
caused	NULL
no	NULL
change	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
that	NULL
a-tcp	NULL
decreased	NULL
E-selectin	NULL
gene	NULL
expression	NULL
by	NULL
an	NULL
NF-	NULL
«	NULL
B-independent	NULL
mechanism	NULL
.	NULL

Effect	NULL
of	NULL
on	NULL
PKC	NULL
.	NULL

a	NULL
«	NULL
-tcp	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
PKC	NULL
in	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
and	NULL
neuroblastoma	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Since	NULL
PKC	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
mediating	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
(	NULL
32	NULL
)	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
a-tcp	NULL
exerted	NULL
its	NULL
effect	NULL
by	NULL
suppressing	NULL
PKC	NULL
activity	NULL
in	NULL
ECs	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
a-tecp	NULL
pretreatment	NULL
of	NULL
ECs	NULL
on	NULL
PKC	NULL
activity	NULL
,	NULL
by	NULL
quantifying	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
80-kD	NULL
,	NULL
myristoylated	NULL
,	NULL
alanine-rich	NULL
C	NULL
kinase	NULL
substrate	NULL
(	NULL
MARCKS	NULL
)	NULL
protein	NULL
,	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
specifically	NULL
phosphorylated	NULL
by	NULL
PKC	NULL
(	NULL
56	NULL
,	NULL
60	NULL
)	NULL
and	NULL
a	NULL
good	NULL
indicator	NULL
of	NULL
PKC	NULL
activity	NULL
(	NULL
61-64	NULL
)	NULL
.	NULL

PMA	NULL
,	NULL
a	NULL
well-established	NULL
activator	NULL
of	NULL
PKC	NULL
,	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
the	NULL
phosphorylation	NULL
of	NULL
MARCKS	NULL
.	NULL

H-7	NULL
pretreatment	NULL
of	NULL
EC	NULL
before	NULL
PMA	NULL
stimulation	NULL
,	NULL
served	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
thought	NULL
the	NULL
inhibition	NULL
of	NULL
MARCKS	NULL
phosphorylation	NULL
was	NULL
not	NULL
dramatic	NULL
in	NULL
this	NULL
specific	NULL
experiment	NULL
.	NULL

Under	NULL
basal	NULL
conditions	NULL
a-tcp	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
phosphorylation	NULL
of	NULL
MARCKS	NULL
.	NULL

PMA	NULL
caused	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
ECs	NULL
were	NULL
stimulated	NULL
with	NULL
IL-1	NULL
,	NULL
MARCKS	NULL
phosphorylation	NULL
was	NULL
not	NULL
significantly	NULL
increased	NULL
;	NULL
nor	NULL
was	NULL
any	NULL
decrease	NULL
in	NULL
protein	NULL
phosphorylation	NULL
observed	NULL
after	NULL
pretreatment	NULL
of	NULL
the	NULL
ECs	NULL
with	NULL
a-tcp	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
IL-1	NULL
induction	NULL
of	NULL
E-selectin	NULL
was	NULL
occurring	NULL
independent	NULL
of	NULL
PKC	NULL
.	NULL

a-Tep	NULL
was	NULL
unable	NULL
to	NULL
inhibit	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
MARCKS	NULL
in	NULL
ECs	NULL
induced	NULL
by	NULL
thrombin	NULL
and	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
known	NULL
to	NULL
activate	NULL
PKC	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
in	NULL
our	NULL
intact	NULL
cell	NULL
system	NULL
,	NULL
a-top	NULL
appeared	NULL
to	NULL
mediate	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
agonist-induced	NULL
adhesion	NULL
independent	NULL
Vitamin	NULL
E	NULL
Inhibits	NULL
Induced	NULL
Monocyte	NULL
Adhesion	NULL
to	NULL
Endothelium	NULL
597	NULL
MARCKS	NULL
|	NULL
kD	NULL
<	NULL
--	NULL
69	NULL
kD	NULL
<	NULL
--	NULL
46	NULL
kD	NULL
$	NULL
a	NULL
-	NULL
»	NULL
-	NULL
Cnentmam|	NULL
<	NULL
-	NULL
:	NULL
.	NULL

>	NULL
Pretreatment	NULL
®	NULL
3	NULL
&	NULL
$	NULL
®1j	NULL
®	NULL
a	NULL
f	NULL
f	NULL
h	NULL
M	NULL
)	NULL
U0	NULL
...	NULL
+4	NULL
Stimulant	NULL
MEDIA	NULL
PMA	NULL
IL-1	NULL
Figure	NULL
10	NULL
.	NULL

Autoradiograph	NULL
of	NULL
an	NULL
SDS-PAGE	NULL
showing	NULL
the	NULL
effect	NULL
of	NULL
a-tep	NULL
(	NULL
TCP	NULL
)	NULL
,	NULL
tocopherol	NULL
acetate	NULL
(	NULL
TA	NULL
)	NULL
,	NULL
and	NULL
butylated	NULL
hydroxytoluene	NULL
(	NULL
BHT	NULL
)	NULL
on	NULL
phosphorylation	NULL
in	NULL
ECs	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Arrows	NULL
on	NULL
the	NULL
left	NULL
of	NULL
the	NULL
figure	NULL
represent	NULL
MARCKS	NULL
and	NULL
p29	NULL
.	NULL

Lanes	NULL
7-4	NULL
,	NULL
basal	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
in	NULL
ECs	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
in	NULL
response	NULL
to	NULL
PMA	NULL
,	NULL
with	NULL
and	NULL
without	NULL
H7	NULL
pretreatment	NULL
prior	NULL
to	NULL
stimulation	NULL
;	NULL
lanes	NULL
7-10	NULL
,	NULL
IL-1	NULL
-stimulated	NULL
phosphorylation	NULL
of	NULL
proteins	NULL
in	NULL
ECs	NULL
.	NULL

TA	NULL
is	NULL
an	NULL
ester	NULL
of	NULL
a-tep	NULL
that	NULL
is	NULL
known	NULL
to	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
PKC	NULL
.	NULL

of	NULL
PKC	NULL
.	NULL

Additionally	NULL
,	NULL
a	NULL
29-kD	NULL
protein	NULL
(	NULL
p29	NULL
)	NULL
,	NULL
initially	NULL
reported	NULL
by	NULL
Levin	NULL
and	NULL
Santell	NULL
to	NULL
undergo	NULL
PKC-independent	NULL
phosphorylation	NULL
in	NULL
ECs	NULL
in	NULL
responses	NULL
to	NULL
IL-1	NULL
(	NULL
65	NULL
,	NULL
66	NULL
)	NULL
,	NULL
was	NULL
also	NULL
noted	NULL
to	NULL
be	NULL
phosphorylated	NULL
in	NULL
our	NULL
studies	NULL
.	NULL

This	NULL
protein	NULL
has	NULL
been	NULL
recently	NULL
found	NULL
to	NULL
be	NULL
identical	NULL
to	NULL
heat	NULL
shock	NULL
protein	NULL
27	NULL
(	NULL
HSP27	NULL
)	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
which	NULL
appears	NULL
to	NULL
be	NULL
PKC	NULL
dependent	NULL
(	NULL
67	NULL
)	NULL
.	NULL

a	NULL
«	NULL
-Tep	NULL
pretreatment	NULL
of	NULL
EC	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
phosphorylation	NULL
of	NULL
p29	NULL
in	NULL
our	NULL
experiment	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Discussion	NULL
a-top	NULL
,	NULL
a	NULL
lipid-soluble	NULL
vitamin	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
protect	NULL
the	NULL
plasma	NULL
membrane	NULL
from	NULL
oxidant	NULL
stress	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
function	NULL
as	NULL
a	NULL
naturally	NULL
occurring	NULL
,	NULL
chain	NULL
breaking	NULL
antioxidant	NULL
(	NULL
21	NULL
,	NULL
26	NULL
)	NULL
.	NULL

a-tep	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
an	NULL
anti-atherogenic	NULL
agent	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Recently	NULL
published	NULL
epidemiological	NULL
studies	NULL
suggest	NULL
a	NULL
beneficial	NULL
role	NULL
for	NULL
«	NULL
-tep	NULL
supplementation	NULL
in	NULL
the	NULL
prevention	NULL
of	NULL
coronary	NULL
events	NULL
(	NULL
68	NULL
,	NULL
69	NULL
)	NULL
,	NULL
lending	NULL
further	NULL
support	NULL
to	NULL
experimental	NULL
observations	NULL
.	NULL

While	NULL
it	NULL
is	NULL
largely	NULL
believed	NULL
that	NULL
a-tcp	NULL
serves	NULL
a	NULL
protective	NULL
function	NULL
by	NULL
preventing	NULL
the	NULL
oxidation	NULL
of	NULL
LDL	NULL
,	NULL
a	NULL
molecule	NULL
believed	NULL
to	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
,	NULL
the	NULL
exact	NULL
mechanisms	NULL
involved	NULL
are	NULL
incompletely	NULL
understood	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
&	NULL
-tcp	NULL
may	NULL
also	NULL
have	NULL
effects	NULL
at	NULL
the	NULL
level	NULL
of	NULL
vascular	NULL
cell	NULL
gene	NULL
expression	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
an	NULL
additional	NULL
and	NULL
novel	NULL
mechanism	NULL
by	NULL
which	NULL
a-tep	NULL
may	NULL
prevent	NULL
the	NULL
progress	NULL
of	NULL
atherosclero-sis	NULL
,	NULL
that	NULL
is	NULL
by	NULL
inhibiting	NULL
induced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
the	NULL
endo-thelium	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
in	NULL
this	NULL
study	NULL
that	NULL
a-tep	NULL
inhibits	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
EC	NULL
with	NULL
an	NULL
ICs	NULL
,	NULL
of	NULL
45	NULL
LM	NULL
,	NULL
consistent	NULL
with	NULL
normal	NULL
plasma	NULL
levels	NULL
.	NULL

a-tep	NULL
was	NULL
not	NULL
cytotoxic	NULL
,	NULL
except	NULL
at	NULL
concentrations	NULL
significantly	NULL
higher	NULL
than	NULL
physiological	NULL
levels	NULL
.	NULL

Furthermore	NULL
,	NULL
inhibition	NULL
of	NULL
the	NULL
agonist-induced	NULL
response	NULL
occurred	NULL
with	NULL
multiple	NULL
stimulators	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
site	NULL
of	NULL
action	NULL
of	NULL
a-tep	NULL
was	NULL
downstream	NULL
from	NULL
the	NULL
agonist	NULL
receptor	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
when	NULL
ECs	NULL
were	NULL
cultured	NULL
in	NULL
media	NULL
containing	NULL
a-tcp	NULL
as	NULL
a	NULL
nutritional	NULL
supplement	NULL
they	NULL
were	NULL
less	NULL
adhesive	NULL
to	NULL
598	NULL
Faruqi	NULL
et	NULL
al	NULL
.	NULL

monocytic	NULL
cells	NULL
after	NULL
IL-1	NULL
treatment	NULL
.	NULL

This	NULL
was	NULL
true	NULL
even	NULL
if	NULL
the	NULL
ECs	NULL
were	NULL
not	NULL
exposed	NULL
to	NULL
a-tep	NULL
during	NULL
the	NULL
``	NULL
pretreatment	NULL
``	NULL
phase	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

Since	NULL
has	NULL
a	NULL
half-life	NULL
of	NULL
56-74	NULL
h	NULL
in	NULL
intact	NULL
EC	NULL
membranes	NULL
(	NULL
70	NULL
)	NULL
,	NULL
its	NULL
presence	NULL
in	NULL
both	NULL
phases	NULL
of	NULL
the	NULL
experiment	NULL
would	NULL
conceivably	NULL
have	NULL
a	NULL
cumulative	NULL
effect	NULL
,	NULL
leading	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
effective	NULL
concentration	NULL
of	NULL
a-tep	NULL
in	NULL
the	NULL
membranes	NULL
of	NULL
ECs	NULL
.	NULL

This	NULL
could	NULL
account	NULL
for	NULL
the	NULL
observation	NULL
that	NULL
ECs	NULL
exposed	NULL
to	NULL
a-tep	NULL
during	NULL
both	NULL
phases	NULL
bound	NULL
the	NULL
least	NULL
number	NULL
of	NULL
monocytic	NULL
cells	NULL
.	NULL

A	NULL
case	NULL
could	NULL
therefore	NULL
be	NULL
made	NULL
for	NULL
a-tep	NULL
supplementation	NULL
during	NULL
procedures	NULL
involving	NULL
EC	NULL
denudation	NULL
,	NULL
since	NULL
in	NULL
vitro	NULL
experiments	NULL
suggest	NULL
that	NULL
wounded	NULL
ECs	NULL
are	NULL
especially	NULL
adhesive	NULL
to	NULL
monocytes	NULL
(	NULL
48	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
a-tep	NULL
was	NULL
a	NULL
function	NULL
of	NULL
its	NULL
antioxidant	NULL
property	NULL
,	NULL
we	NULL
tested	NULL
other	NULL
known	NULL
lipid-soluble	NULL
and	NULL
water-soluble	NULL
antioxidants	NULL
to	NULL
determine	NULL
if	NULL
they	NULL
had	NULL
similar	NULL
inhibitory	NULL
effects	NULL
on	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
.	NULL

The	NULL
results	NULL
varied	NULL
depending	NULL
on	NULL
the	NULL
antioxidant	NULL
tested	NULL
.	NULL

Ascorbate	NULL
was	NULL
found	NULL
to	NULL
be	NULL
stimulatory	NULL
,	NULL
rather	NULL
than	NULL
inhibitory	NULL
,	NULL
which	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
under	NULL
certain	NULL
conditions	NULL
ascorbate	NULL
functions	NULL
as	NULL
a	NULL
pro-oxidant	NULL
,	NULL
rather	NULL
than	NULL
an	NULL
antioxidant	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
ascorbic	NULL
acid	NULL
to	NULL
release	NULL
transitional	NULL
metal	NULL
ions	NULL
from	NULL
protein	NULL
complexes	NULL
leading	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
free	NULL
radicals	NULL
(	NULL
71-77	NULL
)	NULL
.	NULL

Ascorbic	NULL
acid	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
protect	NULL
a-tep	NULL
from	NULL
oxidation	NULL
and	NULL
in	NULL
doing	NULL
so	NULL
enhance	NULL
the	NULL
latter	NULL
's	NULL
antioxidant	NULL
activity	NULL
(	NULL
78-80	NULL
)	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
the	NULL
addition	NULL
of	NULL
ascorbate	NULL
plus	NULL
a-tcp	NULL
led	NULL
to	NULL
no	NULL
net	NULL
effect	NULL
on	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
,	NULL
which	NULL
suggests	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
a-tep	NULL
reduced	NULL
the	NULL
enhancement	NULL
in	NULL
IL-1	NULL
-induced	NULL
adhesion	NULL
caused	NULL
by	NULL
ascorbate	NULL
alone	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
of	NULL
Probucol	NULL
and	NULL
NAC	NULL
,	NULL
two	NULL
structurally	NULL
unrelated	NULL
antioxidants	NULL
,	NULL
could	NULL
make	NULL
a	NULL
case	NULL
for	NULL
a-tep	NULL
functioning	NULL
as	NULL
an	NULL
antioxidant	NULL
in	NULL
exerting	NULL
its	NULL
inhibitory	NULL
effect	NULL
.	NULL

This	NULL
must	NULL
,	NULL
however	NULL
,	NULL
be	NULL
interpreted	NULL
with	NULL
caution	NULL
since	NULL
several	NULL
other	NULL
antioxidants	NULL
had	NULL
no	NULL
inhibitory	NULL
effect	NULL
on	NULL
induced	NULL
adhesion	NULL
.	NULL

Oxidation	NULL
products	NULL
of	NULL
a-tep	NULL
are	NULL
probably	NULL
not	NULL
responsible	NULL
for	NULL
decreased	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
since	NULL
pretreatment	NULL
of	NULL
ECs	NULL
with	NULL
copper	NULL
sulfate	NULL
and	NULL
a-tep	NULL
together	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
the	NULL
latter	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
variability	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
different	NULL
antioxidants	NULL
on	NULL
agonist-induced	NULL
monocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
may	NULL
reflect	NULL
the	NULL
diverse	NULL
free	NULL
radical	NULL
scavenging	NULL
systems	NULL
present	NULL
within	NULL
ECs	NULL
.	NULL

To	NULL
delineate	NULL
the	NULL
mechanisms	NULL
through	NULL
which	NULL
a-tcp	NULL
may	NULL
be	NULL
acting	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
two	NULL
possible	NULL
targets	NULL
along	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
of	NULL
inducible	NULL
adhesion	NULL
molecules	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
PKC	NULL
and	NULL
the	NULL
nuclear	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
role	NULL
of	NULL
PKC	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
cytokine-induced	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
by	NULL
,	NULL
and	NULL
leukocyte	NULL
adhesion	NULL
to	NULL
ECs	NULL
remains	NULL
contro-versial	NULL
,	NULL
with	NULL
some	NULL
studies	NULL
indicating	NULL
a	NULL
role	NULL
for	NULL
the	NULL
enzyme	NULL
,	NULL
and	NULL
other	NULL
reports	NULL
contesting	NULL
this	NULL
(	NULL
32	NULL
,	NULL
53	NULL
,	NULL
81-85	NULL
)	NULL
.	NULL

PMA	NULL
and	NULL
thrombin	NULL
stimulation	NULL
of	NULL
ECs	NULL
did	NULL
cause	NULL
an	NULL
increase	NULL
in	NULL
phosphorylation	NULL
of	NULL
the	NULL
MARCKS	NULL
protein	NULL
and	NULL
a-tep	NULL
did	NULL
not	NULL
inhibit	NULL
this	NULL
event	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
PKC-independent	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
the	NULL
vitamin	NULL
.	NULL

Further	NULL
evidence	NULL
supporting	NULL
this	NULL
conclusion	NULL
is	NULL
the	NULL
inability	NULL
of	NULL
a-tep	NULL
to	NULL
prevent	NULL
the	NULL
IL-1	NULL
-induced	NULL
phosphorylation	NULL
of	NULL
a	NULL
29-kD	NULL
protein	NULL
in	NULL
EC	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
,	NULL
the	NULL
phosphorylation	NULL
of	NULL
which	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
PKC	NULL
dependent	NULL
(	NULL
67	NULL
)	NULL
.	NULL

A	NULL
number	NULL
of	NULL
different	NULL
cytokines	NULL
and	NULL
biological	NULL
response	NULL
modifiers	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exert	NULL
their	NULL
cellular	NULL
effects	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
transcription	NULL
factors	NULL
,	NULL
a	NULL
notable	NULL
example	NULL
of	NULL
which	NULL
is	NULL
the	NULL
trimolecular	NULL
complex	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
in	NULL
ECs	NULL
,	NULL
has	NULL
revealed	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
(	NULL
39	NULL
)	NULL
.	NULL

The	NULL
oxidation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
free	NULL
radicals	NULL
has	NULL
been	NULL
hypothesized	NULL
as	NULL
one	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
transcription	NULL
factor	NULL
is	NULL
activated	NULL
(	NULL
20	NULL
,	NULL
41	NULL
,	NULL
86	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-1	NULL
,	NULL
TNF-a	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
PMA	NULL
have	NULL
all	NULL
been	NULL
reported	NULL
to	NULL
increase	NULL
intracellular	NULL
levels	NULL
of	NULL
free	NULL
radicals	NULL
(	NULL
86	NULL
)	NULL
.	NULL

Although	NULL
a	NULL
*'cause-effect	NULL
``	NULL
relationship	NULL
has	NULL
not	NULL
been	NULL
directly	NULL
demonstrated	NULL
,	NULL
certain	NULL
thiol-containing	NULL
antioxidants	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
prevent	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
some	NULL
lymphoid	NULL
cell	NULL
lines	NULL
(	NULL
20	NULL
,	NULL
41	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
free	NULL
radicals	NULL
in	NULL
gene	NULL
activation	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
then	NULL
,	NULL
that	NULL
a-tep	NULL
was	NULL
acting	NULL
similarly	NULL
in	NULL
our	NULL
EC	NULL
system	NULL
,	NULL
inhibiting	NULL
E-selectin	NULL
gene	NULL
transcription	NULL
by	NULL
preventing	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
free	NULL
radicals	NULL
generated	NULL
within	NULL
the	NULL
cells	NULL
.	NULL

While	NULL
we	NULL
have	NULL
confirmed	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IL-1	NULL
in	NULL
EC	NULL
,	NULL
a-tep	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
at	NULL
vitamin	NULL
concentrations	NULL
that	NULL
caused	NULL
marked	NULL
decreases	NULL
in	NULL
E-selectin	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
.	NULL

Our	NULL
oligomer	NULL
probe	NULL
for	NULL
these	NULL
studies	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
E-selectin	NULL
promoter	NULL
and	NULL
therefore	NULL
the	NULL
nuclear	NULL
factor	NULL
we	NULL
quantitated	NULL
was	NULL
of	NULL
direct	NULL
relevance	NULL
to	NULL
our	NULL
other	NULL
observations	NULL
.	NULL

It	NULL
must	NULL
be	NULL
kept	NULL
in	NULL
mind	NULL
,	NULL
however	NULL
,	NULL
that	NULL
a	NULL
family	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
are	NULL
known	NULL
to	NULL
exist	NULL
and	NULL
that	NULL
some	NULL
of	NULL
these	NULL
might	NULL
be	NULL
much	NULL
more	NULL
sensitive	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
antioxidants	NULL
.	NULL

A	NULL
report	NULL
appeared	NULL
during	NULL
revision	NULL
of	NULL
this	NULL
manuscript	NULL
that	NULL
supports	NULL
the	NULL
contention	NULL
that	NULL
antioxidants	NULL
,	NULL
in	NULL
their	NULL
case	NULL
PDTC	NULL
,	NULL
do	NULL
not	NULL
suppress	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
using	NULL
the	NULL
E-selectin	NULL
consensus	NULL
sequence	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
(	NULL
87	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
a-tep	NULL
exerts	NULL
its	NULL
effects	NULL
remain	NULL
to	NULL
be	NULL
elucidated	NULL
.	NULL

However	NULL
,	NULL
our	NULL
study	NULL
points	NULL
to	NULL
a	NULL
novel	NULL
target	NULL
site	NULL
for	NULL
the	NULL
protective	NULL
action	NULL
of	NULL
a-tep	NULL
in	NULL
which	NULL
this	NULL
vitamin	NULL
acts	NULL
at	NULL
the	NULL
cellular	NULL
level	NULL
to	NULL
decrease	NULL
E-selectin	NULL
gene	NULL
expression	NULL
in	NULL
ECs	NULL
with	NULL
a	NULL
consequent	NULL
decrease	NULL
in	NULL
leukocyte	NULL
adhesion	NULL
.	NULL

In	NULL
so	NULL
doing	NULL
,	NULL
a-top	NULL
may	NULL
prove	NULL
beneficial	NULL
in	NULL
multiple	NULL
pathological	NULL
situations	NULL
involving	NULL
the	NULL
adhesion	NULL
of	NULL
leukocytes	NULL
,	NULL
including	NULL
inflammation	NULL
,	NULL
and	NULL
atherosclerosis	NULL
.	NULL

Acknowledgments	NULL
We	NULL
wish	NULL
to	NULL
thank	NULL
Mr.	NULL
Earl	NULL
Poptic	NULL
and	NULL
Drs	NULL
.	NULL

Philip	NULL
Howe	NULL
,	NULL
Julie	NULL
Tebo	NULL
,	NULL
Guy	NULL
Chisolm	NULL
,	NULL
and	NULL
Thomas	NULL
Hamilton	NULL
,	NULL
(	NULL
Cleveland	NULL
Clinic	NULL
)	NULL
for	NULL
helpful	NULL
discussions	NULL
during	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
and	NULL
Dr.	NULL
Walter	NULL
Newman	NULL
(	NULL
Otsuka	NULL
Pharmaceuticals	NULL
,	NULL
Rockvilie	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
generously	NULL
providing	NULL
the	NULL
monoclonal	NULL
antibody	NULL
7A9	NULL
and	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
E-selectin	NULL
.	NULL

Human	NULL
umbilical	NULL
vein	NULL
EC	NULL
were	NULL
prepared	NULL
from	NULL
tissue	NULL
provided	NULL
by	NULL
the	NULL
Perinatal	NULL
Clinical	NULL
Research	NULL
Center	NULL
(	NULL
NIH	NULL
USPHS	NULL
MOL	NULL
RR	NULL
00210	NULL
)	NULL
,	NULL
Cleveland	NULL
Metrohealth	NULL
Hospital	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
NIH	NULL
)	NULL
grant	NULL
HL-34727	NULL
.	NULL

P.	NULL
E.	NULL
DiCorleto	NULL
was	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Research	NULL
Career	NULL
Development	NULL
Award	NULL
(	NULL
HL-1561	NULL
)	NULL
from	NULL
NIH	NULL
during	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
.	NULL

References	NULL
I.	NULL
Ross	NULL
,	NULL
R.	NULL
1986	NULL
.	NULL

The	NULL
pathogenesis	NULL
of	NULL
atherosclerosis-an	NULL
update	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

314:488-500	NULL
.	NULL

2	NULL
.	NULL

Gerrity	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
H.	NULL
K.	NULL
Naito	NULL
,	NULL
M.	NULL
Richardson	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Schwartz	NULL
.	NULL

1979	NULL
.	NULL

Dietary	NULL
induced	NULL
atherogenesis	NULL
in	NULL
swine	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

95:775-792	NULL
.	NULL

3	NULL
.	NULL

Gerrity	NULL
,	NULL
R.	NULL
G.	NULL
1981	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
monocyte	NULL
in	NULL
atherogenesis	NULL
.	NULL

I	NULL
.	NULL

Transition	NULL
of	NULL
blood-borne	NULL
monocytes	NULL
into	NULL
foam	NULL
cells	NULL
in	NULL
fatty	NULL
lesions	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

103:181-190	NULL
.	NULL

4	NULL
.	NULL

Faggiotto	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Ross	NULL
,	NULL
and	NULL
L.	NULL
Harker	NULL
.	NULL

1984	NULL
.	NULL

Studies	NULL
of	NULL
hypercholesterolemia	NULL
in	NULL
the	NULL
nonhuman	NULL
primate	NULL
.	NULL

L.	NULL
Changes	NULL
that	NULL
lead	NULL
to	NULL
fatty	NULL
streak	NULL
formation	NULL
.	NULL

Arteriosclerosis	NULL
,	NULL
4:323-340	NULL
.	NULL

5	NULL
.	NULL

Taylor	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Lewis	NULL
.	NULL

1986	NULL
.	NULL

Endothelial	NULL
cell	NULL
proliferation	NULL
and	NULL
monocyte	NULL
adhesion	NULL
to	NULL
atherosclerotic	NULL
lesions	NULL
of	NULL
white	NULL
carneau	NULL
pigeons	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

125:152-160	NULL
.	NULL

6	NULL
.	NULL

Joris	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Zand	NULL
,	NULL
J.	NULL
J.	NULL
Nunnari	NULL
,	NULL
F.	NULL
J.	NULL
Krolikowski	NULL
,	NULL
and	NULL
G.	NULL
Majno	NULL
.	NULL

1983	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
pathogenesis	NULL
of	NULL
atherosclerosis	NULL
.	NULL

I.	NULL
Adhesion	NULL
and	NULL
emigration	NULL
of	NULL
mononuclear	NULL
cells	NULL
in	NULL
the	NULL
aorta	NULL
of	NULL
hypercholesterolemia	NULL
rats	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

113:341-358	NULL
.	NULL

7	NULL
.	NULL

Schwartz	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
E.	NULL
A.	NULL
Sprague	NULL
,	NULL
J.	NULL
L.	NULL
Kelley	NULL
,	NULL
A.	NULL
J.	NULL
Valente	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Suenram	NULL
.	NULL

1985	NULL
.	NULL

Aortic	NULL
intimal	NULL
monocyte	NULL
recruitment	NULL
in	NULL
the	NULL
normo	NULL
and	NULL
hypercho-lesterolemic	NULL
baboon	NULL
.	NULL

Virchows	NULL
Arch	NULL
.	NULL

A	NULL
Pathol	NULL
.	NULL

Anat	NULL
.	NULL

Histopathol	NULL
.	NULL

405:175-191	NULL
.	NULL

8	NULL
.	NULL

DiCorleto	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Chisolm	NULL
.	NULL

1986	NULL
.	NULL

Participation	NULL
of	NULL
the	NULL
endothelium	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

Prog	NULL
.	NULL

Lipid	NULL
Res	NULL
.	NULL

25:365-374	NULL
.	NULL

9	NULL
.	NULL

Cotran	NULL
,	NULL
R.	NULL
S.	NULL
1987	NULL
.	NULL

New	NULL
roles	NULL
for	NULL
the	NULL
endothelium	NULL
in	NULL
inflammation	NULL
and	NULL
immunity	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

129:407-413	NULL
.	NULL

10	NULL
.	NULL

Farugi	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
DiCorleto	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
monocyte	NULL
recruitment	NULL
and	NULL
accumulation	NULL
.	NULL

Br	NULL
.	NULL

Heart	NULL
J	NULL
.	NULL

69	NULL
:	NULL
$	NULL
19-S29	NULL
.	NULL

11	NULL
.	NULL

Fajardo	NULL
,	NULL
L.	NULL
F.	NULL
1989	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Pathol	NULL
.	NULL

92:241-250	NULL
.	NULL

12	NULL
.	NULL

Jaffe	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

1987	NULL
.	NULL

Cell	NULL
biology	NULL
of	NULL
endothelial	NULL
cells	NULL
.	NULL

Hum	NULL
.	NULL

Pathol	NULL
.	NULL

18:234-239	NULL
.	NULL

13	NULL
.	NULL

Crawford	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
D.	NULL
H.	NULL
Blankenhorn	NULL
.	NULL

1991	NULL
.	NULL

Arterial	NULL
wall	NULL
oxygenation	NULL
,	NULL
oxyradicals	NULL
,	NULL
and	NULL
atherosclerosis	NULL
.	NULL

Atherosclerosis	NULL
.	NULL

89:97-108	NULL
.	NULL

14	NULL
.	NULL

Farber	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
M.	NULL
E.	NULL
Kyle	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Coleman	NULL
.	NULL

1990	NULL
.	NULL

Biology	NULL
of	NULL
disease	NULL
.	NULL

Mechanisms	NULL
of	NULL
cell	NULL
injury	NULL
by	NULL
activated	NULL
oxygen	NULL
species	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

62:670-679	NULL
.	NULL

15	NULL
.	NULL

Steinberg	NULL
,	NULL
D.	NULL
1992	NULL
.	NULL

Antioxidants	NULL
in	NULL
the	NULL
prevention	NULL
of	NULL
human	NULL
atherosclerosis	NULL
.	NULL

Circulation	NULL
.	NULL

85:2338-2344	NULL
.	NULL

16	NULL
.	NULL

Rosen	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

A.	NULL
Freeman	NULL
.	NULL

1984	NULL
.	NULL

Detection	NULL
of	NULL
superoxide	NULL
generated	NULL
by	NULL
endothelial	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

81:7269-7273	NULL
.	NULL

17	NULL
.	NULL

Matsubara	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
M.	NULL
Ziff	NULL
.	NULL

1986	NULL
.	NULL

Superoxide	NULL
anion	NULL
release	NULL
by	NULL
human	NULL
endothelial	NULL
cells	NULL
:	NULL
synergism	NULL
between	NULL
a	NULL
phorbol	NULL
ester	NULL
and	NULL
a	NULL
calcium	NULL
ionophore	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

127:207-210	NULL
.	NULL

18	NULL
.	NULL

Klebanoff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
M.	NULL
A.	NULL
Vadas	NULL
,	NULL
J.	NULL
M.	NULL
Harlan	NULL
,	NULL
L.	NULL
H.	NULL
Sparks	NULL
,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
J.	NULL
M.	NULL
Agosti	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Waltersdorph	NULL
.	NULL

1986	NULL
.	NULL

Stimulation	NULL
of	NULL
neutrophils	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

136:4220-4225	NULL
.	NULL

19	NULL
.	NULL

Meier	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
H.	NULL
Radeke	NULL
,	NULL
S.	NULL
Selle	NULL
,	NULL
M.	NULL
Younes	NULL
,	NULL
H.	NULL
Sies	NULL
,	NULL
K.	NULL
Resch	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Habermehl	NULL
.	NULL

1989	NULL
.	NULL

Human	NULL
fibroblasts	NULL
release	NULL
reactive	NULL
oxygen	NULL
species	NULL
in	NULL
response	NULL
to	NULL
interleukin-1	NULL
or	NULL
tumour	NULL
necrosis	NULL
factor-a	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

263:539-545	NULL
.	NULL

20	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Rieber	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerie	NULL
.	NULL

1991	NULL
.	NULL

Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

10:2247-2258	NULL
.	NULL

21	NULL
.	NULL

Burton	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
and	NULL
K.	NULL
U.	NULL
Ingold	NULL
.	NULL

1989	NULL
.	NULL

Vitamin	NULL
E	NULL
as	NULL
an	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
antioxidant	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:7-22	NULL
.	NULL

22	NULL
.	NULL

Janero	NULL
,	NULL
D.	NULL
R.	NULL
1991	NULL
.	NULL

Therapeutic	NULL
potential	NULL
of	NULL
vitamin	NULL
E	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
spontaneous	NULL
atherosclerosis	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

&	NULL
Med	NULL
.	NULL

11:129-144	NULL
.	NULL

23	NULL
.	NULL

Packer	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
Landvik	NULL
.	NULL

1989	NULL
.	NULL

Vitamin	NULL
E	NULL
:	NULL
introduction	NULL
to	NULL
biochemistry	NULL
and	NULL
health	NULL
benefits	NULL
.	NULL

Ann	NULL
.	NULL

N.Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:1-6	NULL
.	NULL

24	NULL
.	NULL

Tengerdy	NULL
,	NULL
R.	NULL
P.	NULL
1989	NULL
.	NULL

Vitamin	NULL
E	NULL
,	NULL
immune	NULL
response	NULL
,	NULL
and	NULL
disease	NULL
resistance	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:335-344	NULL
.	NULL

25	NULL
.	NULL

Corwin	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
K.	NULL
Gordon	NULL
.	NULL

1982	NULL
.	NULL

Vitamin	NULL
E	NULL
and	NULL
immune	NULL
regulation	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

393:437-451	NULL
.	NULL

26	NULL
.	NULL

Chow	NULL
,	NULL
C.	NULL
K.	NULL
1991	NULL
.	NULL

Vitamin	NULL
E	NULL
and	NULL
oxidative	NULL
stress	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

Med	NULL
.	NULL

11:215-232	NULL
.	NULL

27	NULL
.	NULL

Urano	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Matsuo	NULL
.	NULL

1989	NULL
.	NULL

Membrane-stabilizing	NULL
effect	NULL
of	NULL
vitamin	NULL
E.	NULL
Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:524-526	NULL
.	NULL

28	NULL
.	NULL

Kaneko	NULL
,	NULL
T.	NULL
,	NULL
S-I	NULL
.	NULL

Nakano	NULL
,	NULL
and	NULL
M.	NULL
Matsuo	NULL
.	NULL

1991	NULL
.	NULL

Protective	NULL
effect	NULL
on	NULL
vitamin	NULL
E	NULL
on	NULL
linoleic	NULL
acid	NULL
hydroperoxide-induced	NULL
injury	NULL
to	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Lipids	NULL
.	NULL

26:345-348	NULL
.	NULL

29	NULL
.	NULL

Kagan	NULL
,	NULL
V.	NULL
E.	NULL
1989	NULL
.	NULL

Tocopherol	NULL
stabilizes	NULL
membrane	NULL
against	NULL
phospholipase	NULL
A	NULL
,	NULL
free	NULL
fatty	NULL
acids	NULL
,	NULL
and	NULL
lysophospholipids	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:121-135	NULL
.	NULL

30	NULL
.	NULL

Nishizuka	NULL
,	NULL
Y	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
family	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
for	NULL
signal	NULL
transduction	NULL
.	NULL

JAMA	NULL
(	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL
)	NULL

.	NULL

262:1826-1833	NULL
.	NULL

31	NULL
.	NULL

Farago	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Y.	NULL
Nishizuka	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
in	NULL
transmembrane	NULL
signalling	NULL
.	NULL

FEBS	NULL
(	NULL
Fed	NULL
.	NULL

Eur	NULL
.	NULL

Biochem	NULL
.	NULL

Soc	NULL
.	NULL
)	NULL

Lett	NULL
.	NULL

268:350-354	NULL
.	NULL

32	NULL
.	NULL

DiCorleto	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
de	NULL
la	NULL
Motte	NULL
.	NULL

1989	NULL
.	NULL

Thrombin	NULL
causes	NULL
increased	NULL
monocytic-cell	NULL
adhesion	NULL
to	NULL
endothelial	NULL
cells	NULL
through	NULL
a	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
pathway	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

264:71-77	NULL
.	NULL

33	NULL
.	NULL

Mahoney	NULL
,	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
A.	NULL
Azzi	NULL
.	NULL

1988	NULL
.	NULL

Vitamin	NULL
E	NULL
inhibits	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

154:694-697	NULL
.	NULL

34	NULL
.	NULL

Boscoboinik	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
Szewezyk	NULL
,	NULL
C.	NULL
Hensey	NULL
,	NULL
and	NULL
A.	NULL
Azzi	NULL
.	NULL

1991	NULL
.	NULL

Inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
by	NULL
a-tocopherol	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:6188-6194	NULL
.	NULL

35	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
J.	NULL
S.	NULL
Pober	NULL
,	NULL
D.	NULL
L.	NULL
Mendrick	NULL
,	NULL
R.	NULL
S.	NULL
Cotran	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gibrone	NULL
,	NULL
Jr.	NULL
1987	NULL
.	NULL

Identification	NULL
of	NULL
an	NULL
inducible	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

$	NULL
4:9238-9242	NULL
.	NULL

36	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
S.	NULL
Stengelin	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1989	NULL
.	NULL

Endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
:	NULL
an	NULL
inducible	NULL
receptor	NULL
for	NULL
neutrophils	NULL
related	NULL
to	NULL
complement	NULL
regulatory	NULL
proteins	NULL
and	NULL
lectins	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

243:1160-	NULL
1165	NULL
.	NULL

37	NULL
.	NULL

Leeuwenberg	NULL
,	NULL
J.	NULL
F.	NULL
M.	NULL
,	NULL
T.	NULL
M.	NULL
A	NULL
.	NULL

A.	NULL
Jeunhomme	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Buurman	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
ELAM-1	NULL
in	NULL
adhesion	NULL
of	NULL
monocytes	NULL
to	NULL
activated	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

35:335-341	NULL
.	NULL

38	NULL
.	NULL

Carlos	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Kovach	NULL
,	NULL
B.	NULL
Schwartz	NULL
,	NULL
M.	NULL
Rosa	NULL
,	NULL
B.	NULL
Newman	NULL
,	NULL
E.	NULL
Wayner	NULL
,	NULL
C.	NULL
Benjamin	NULL
,	NULL
L.	NULL
Osborn	NULL
,	NULL
R.	NULL
Lobb	NULL
,	NULL
and	NULL
J.	NULL
Harlan	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
monocytes	NULL
bind	NULL
to	NULL
two	NULL
cytokine-induced	NULL
adhesive	NULL
ligands	NULL
on	NULL
cultured	NULL
human	NULL
endothelial	NULL
cells	NULL
:	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

Blood	NULL
.	NULL

77:2266-2271	NULL
.	NULL

Vitamin	NULL
E	NULL
Inhibits	NULL
Induced	NULL
Monocyte	NULL
Adhesion	NULL
to	NULL
Endothelium	NULL
599	NULL
39	NULL
.	NULL

Collins	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Williams	NULL
,	NULL
G.	NULL
I.	NULL
Johnston	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
R.	NULL
Eddy	NULL
,	NULL
T.	NULL
Shows	NULL
,	NULL
M.	NULL
A.	NULL
Gimbrone	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Bevilacqua	NULL
.	NULL

1991	NULL
.	NULL

Structure	NULL
and	NULL
chromosomal	NULL
location	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:2466-2473	NULL
.	NULL

40	NULL
.	NULL

Whelan	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Ghersa	NULL
,	NULL
R.	NULL
H.	NULL
van	NULL
Huijsduijnen	NULL
,	NULL
J	NULL
.	NULL

Gray	NULL
,	NULL
G.	NULL
Chandra	NULL
,	NULL
F.	NULL
Talabot	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
DeLamarter	NULL
.	NULL

1991	NULL
.	NULL

An	NULL
NFxB-like	NULL
factor	NULL
is	NULL
essential	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
cytokine	NULL
induction	NULL
of	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

19:2645-2653	NULL
.	NULL

41	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
B.	NULL
Meier	NULL
,	NULL
D.	NULL
N.	NULL
Miinnel	NULL
,	NULL
W.	NULL
Drioge	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1992	NULL
.	NULL

Dithiocarbamates	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
B	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:1181-1194	NULL
.	NULL

42	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

NF-kB	NULL
and	NULL
related	NULL
proteins	NULL
:	NULL
rel/dorsal	NULL
homologies	NULL
meet	NULL
ankyrin-like	NULL
repeats	NULL
.	NULL

TIBS	NULL
(	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL
)	NULL

.	NULL

17:135-140	NULL
.	NULL

43	NULL
.	NULL

Lewis	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
J.	NULL
C.	NULL
Hoak	NULL
,	NULL
R.	NULL
D.	NULL
Maca	NULL
,	NULL
and	NULL
G.	NULL
Fry	NULL
.	NULL

1973	NULL
.	NULL

Replication	NULL
of	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

181:453-456	NULL
.	NULL

44	NULL
.	NULL

Thornton	NULL
,	NULL
$	NULL
.	NULL

C.	NULL
,	NULL
S.	NULL
N.	NULL
Mueller	NULL
,	NULL
and	NULL
E.	NULL
M.	NULL
Levine	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
endothelial	NULL
cells	NULL
:	NULL
Use	NULL
of	NULL
heparin	NULL
in	NULL
cloning	NULL
and	NULL
long-term	NULL
serial	NULL
cultivation	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

222:623-625	NULL
.	NULL

45	NULL
.	NULL

Recalde	NULL
,	NULL
H.	NULL
R.	NULL
1984	NULL
.	NULL

A	NULL
simple	NULL
method	NULL
of	NULL
obtaining	NULL
monocytes	NULL
in	NULL
suspen-sion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
.	NULL

69:71-77	NULL
.	NULL

46	NULL
.	NULL

DiCorieto	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
de	NULL
la	NULL
Motte	NULL
.	NULL

1989	NULL
.	NULL

Role	NULL
of	NULL
cell	NULL
surface	NULL
carbohydrate	NULL
moieties	NULL
in	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
to	NULL
endothelium	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:3666-3672	NULL
.	NULL

47	NULL
.	NULL

Boyum	NULL
,	NULL
A	NULL
.	NULL

1968	NULL
.	NULL

Isolation	NULL
of	NULL
mononuclear	NULL
cells	NULL
and	NULL
granulocytes	NULL
from	NULL
human	NULL
blood	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

21	NULL
(	NULL
Suppl	NULL
.	NULL

97	NULL
)	NULL
:77-83	NULL
.	NULL

48	NULL
.	NULL

DiCorleto	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
de	NULL
la	NULL
Motte	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
adhesion	NULL
of	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
U937	NULL
to	NULL
cultured	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

75:1153-1161	NULL
.	NULL

49	NULL
.	NULL

Fox	NULL
,	NULL
P.	NULL
L.	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
DiCorleto	NULL
.	NULL

1984	NULL
.	NULL

Regulation	NULL
of	NULL
production	NULL
of	NULL
a	NULL
platelet-derived	NULL
growth	NULL
factor-like	NULL
protein	NULL
by	NULL
cultured	NULL
bovine	NULL
aortic	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

121:298-308	NULL
.	NULL

50	NULL
.	NULL

Graber	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
V.	NULL
Gopal	NULL
,	NULL
T.	NULL
Wilson	NULL
,	NULL
L.	NULL
Beall	NULL
,	NULL
T.	NULL
Polte	NULL
,	NULL
and	NULL
W.	NULL
Newman	NULL
.	NULL

1990	NULL
.	NULL

T	NULL
cells	NULL
bind	NULL
to	NULL
cytokine-activated	NULL
endothelial	NULL
cells	NULL
via	NULL
a	NULL
novel	NULL
,	NULL
inducible	NULL
sialoglycoprotein	NULL
and	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:819-830	NULL
.	NULL

51	NULL
.	NULL

Shankar	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
A.	NULL
de	NULL
la	NULL
Motte	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
DiCorleto	NULL
.	NULL

1992	NULL
.	NULL

3-Deazaadenos-ine	NULL
inhibits	NULL
thrombin-stimulated	NULL
platelet-derived	NULL
growth	NULL
factor	NULL
production	NULL
and	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule-l-mediated	NULL
monocytic	NULL
cell	NULL
adhesion	NULL
in	NULL
human	NULL
aortic	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:9376-9382	NULL
.	NULL

52	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
A.	NULL
E.	NULL
Przybyla	NULL
,	NULL
R.	NULL
J.	NULL
MacDonald	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Rutter	NULL
.	NULL

1979	NULL
.	NULL

Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
enriched	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
.	NULL

18:5294-5299	NULL
.	NULL

53	NULL
.	NULL

Montgomery	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
L.	NULL
Osborn	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
R.	NULL
Tizard	NULL
,	NULL
D.	NULL
Goff	NULL
,	NULL
C.	NULL
Vassallo	NULL
,	NULL
P.	NULL
I.	NULL
Tar	NULL
,	NULL
K.	NULL
Bomsztyk	NULL
,	NULL
R.	NULL
Lobb	NULL
,	NULL
J.	NULL
M.	NULL
Harlan	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Pohliman	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
endothelial-leukocyte	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ELAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

88:6523-6527	NULL
.	NULL

54	NULL
.	NULL

Datta	NULL
,	NULL
S.	NULL
,	NULL
C-J	NULL
.	NULL

Soong	NULL
,	NULL
D.	NULL
M.	NULL
Wang	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Harter	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
purified	NULL
adenovirus	NULL
289-amino-acid	NULL
E1A	NULL
protein	NULL
activates	NULL
RNA	NULL
polymerase	NULL
III	NULL
transcription	NULL
in	NULL
vitro	NULL
and	NULL
alters	NULL
transcription	NULL
factor	NULL
TFIIIC	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5297-5304	NULL
.	NULL

55	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1488	NULL
.	NULL

56	NULL
.	NULL

Rozengurt	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Rodriguez-Pena	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1983	NULL
.	NULL

Phorbol	NULL
esters	NULL
,	NULL
phospholipase	NULL
C	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
rapidly	NULL
stimulate	NULL
the	NULL
phosphorylation	NULL
of	NULL
a	NULL
M	NULL
,	NULL
80,000	NULL
protein	NULL
in	NULL
intact	NULL
quiescent	NULL
3T3	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

80:7244-7248	NULL
.	NULL

57	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
1970	NULL
.	NULL

Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

227:680-685	NULL
.	NULL

58	NULL
.	NULL

Stihelin	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
K.	NULL
F.	NULL
Gey	NULL
,	NULL
M.	NULL
Eichholzer	NULL
,	NULL
E.	NULL
Liidin	NULL
,	NULL
and	NULL
G.	NULL
Brubacher	NULL
.	NULL

1989	NULL
.	NULL

Cancer	NULL
mortality	NULL
and	NULL
vitamin	NULL
E	NULL
status	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:391-399	NULL
.	NULL

59	NULL
.	NULL

Esterbauer	NULL
,	NULL
H.	NULL
,	NULL
G	NULL
.	NULL

Strieg	NULL
!	NULL

,	NULL
H.	NULL
Puhl	NULL
,	NULL
S.	NULL
Oberreither	NULL
,	NULL
M.	NULL
Rotheneder	NULL
,	NULL
M.	NULL
El-Saadani	NULL
,	NULL
and	NULL
G.	NULL
Jiirgens	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
role	NULL
of	NULL
vitamin	NULL
E	NULL
and	NULL
carotenoids	NULL
in	NULL
preventing	NULL
oxidation	NULL
of	NULL
low	NULL
density	NULL
lipoproteins	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

570:254-267	NULL
.	NULL

60	NULL
.	NULL

Blackshear	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
L.	NULL
Wen	NULL
,	NULL
B.	NULL
P.	NULL
Glynn	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Witters	NULL
.	NULL

1986	NULL
.	NULL

Protein	NULL
kinase	NULL
C-stimulated	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
of	NULL
a	NULL
M	NULL
,	NULL
80,000	NULL
protein	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
phorbol	NULL
esters	NULL
and	NULL
growth	NULL
factors	NULL
in	NULL
intact	NULL
fibroblasts	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

261:1459-1469	NULL
.	NULL

61	NULL
.	NULL

Stabel	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Parker	NULL
.	NULL

1991	NULL
.	NULL

Protein	NULL
kinase	NULL
C.	NULL
Pharmacol	NULL
.	NULL

&	NULL
Ther	NULL
.	NULL

51:71-95	NULL
.	NULL

62	NULL
.	NULL

Bhat	NULL
,	NULL
N.	NULL
R.	NULL
1991	NULL
.	NULL

Phosphorylation	NULL
of	NULL
MARCKS	NULL
(	NULL
80-kDa	NULL
)	NULL
protein	NULL
,	NULL
a	NULL
major	NULL
substrate	NULL
for	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
oligodendroglial	NULL
progenitors	NULL
.	NULL

J.	NULL
Neurosci	NULL
.	NULL

Res	NULL
.	NULL

30:447-454	NULL
.	NULL

600	NULL
Farugi	NULL
et	NULL
al	NULL
.	NULL

63	NULL
.	NULL

Hartwig	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
M.	NULL
Thelen	NULL
,	NULL
A.	NULL
Rosen	NULL
,	NULL
P.	NULL
A.	NULL
Janmey	NULL
,	NULL
A.	NULL
C.	NULL
Nairn	NULL
,	NULL
and	NULL
A.	NULL
Aderem	NULL
.	NULL

1992	NULL
.	NULL

MARCKS	NULL
is	NULL
an	NULL
actin	NULL
filament	NULL
crosslinking	NULL
protein	NULL
regulated	NULL
by	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
calcium-calmodulin	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

356:618-622	NULL
.	NULL

64	NULL
.	NULL

Wolfman	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
I.	NULL
G.	NULL
Macara	NULL
.	NULL

1987	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
diacylglycerol	NULL
and	NULL
decreased	NULL
phorbol	NULL
ester	NULL
sensitivity	NULL
in	NULL
ras-transformed	NULL
fibroblasts	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

325:359-361	NULL
.	NULL

65	NULL
.	NULL

Levin	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
L.	NULL
Santell	NULL
.	NULL

1991	NULL
.	NULL

Phosphorylation	NULL
of	NULL
an	NULL
M	NULL
,	NULL
=	NULL
29,000	NULL
protein	NULL
by	NULL
IL-1	NULL
is	NULL
susceptible	NULL
to	NULL
partial	NULL
down-regulation	NULL
after	NULL
endothelial	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3772-3778	NULL
.	NULL

66	NULL
.	NULL

Levin	NULL
,	NULL
E.	NULL
G.	NULL
,	NULL
and	NULL
L.	NULL
Santell	NULL
.	NULL

1991	NULL
.	NULL

Thrombin-	NULL
and	NULL
histamine-induced	NULL
signal	NULL
transduction	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Stimulation	NULL
and	NULL
agonist-dependent	NULL
desensitization	NULL
of	NULL
protein	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:174-181	NULL
.	NULL

67	NULL
.	NULL

Santell	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
S.	NULL
Bartfeld	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Levin	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
protein	NULL
transiently	NULL
phosphorylated	NULL
by	NULL
activators	NULL
of	NULL
endothelial	NULL
cell	NULL
function	NULL
as	NULL
the	NULL
heat-shock	NULL
protein	NULL
HSP27	NULL
.	NULL

A	NULL
possible	NULL
role	NULL
for	NULL
protein	NULL
kinase	NULL
C.	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

284:705-710	NULL
.	NULL

68	NULL
.	NULL

Stampfer	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
C.	NULL
H.	NULL
Hennekens	NULL
,	NULL
J.	NULL
E.	NULL
Manson	NULL
,	NULL
G.	NULL
A.	NULL
Colditz	NULL
,	NULL
B.	NULL
Rosner	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Willet	NULL
.	NULL

1993	NULL
.	NULL

Vitamin	NULL
E	NULL
consumption	NULL
and	NULL
the	NULL
risk	NULL
of	NULL
coronary	NULL
disease	NULL
in	NULL
women	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

328:1444-1449	NULL
.	NULL

69	NULL
.	NULL

Rimm	NULL
,	NULL
E.	NULL
B.	NULL
,	NULL
M.	NULL
J.	NULL
Stampfer	NULL
,	NULL
A.	NULL
Ascherio	NULL
,	NULL
E.	NULL
Giovanucci	NULL
,	NULL
G.	NULL
A.	NULL
Colditz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Willet	NULL
.	NULL

1993	NULL
.	NULL

Vitamin	NULL
E	NULL
consumption	NULL
and	NULL
the	NULL
risk	NULL
of	NULL
coronary	NULL
disease	NULL
in	NULL
men	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

328:1450-1456	NULL
.	NULL

70	NULL
.	NULL

Chan	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
K.	NULL
Tran	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
uptake	NULL
of	NULL
(	NULL
R	NULL
,	NULL
R.R	NULL
)	NULL
alpha-tocopherol	NULL
by	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
culture	NULL
.	NULL

Lipids	NULL
.	NULL

25:17-21	NULL
.	NULL

71	NULL
.	NULL

Wills	NULL
,	NULL
E.	NULL
D.	NULL
1966	NULL
.	NULL

Mechanisms	NULL
of	NULL
lipid	NULL
peroxide	NULL
formation	NULL
in	NULL
animal	NULL
tissues	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

99:667-676	NULL
.	NULL

72	NULL
.	NULL

Laudicinia	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Marnett	NULL
.	NULL

1990	NULL
.	NULL

Enhancement	NULL
of	NULL
hydroperoxide-dependent	NULL
lipid	NULL
peroxidation	NULL
in	NULL
rat	NULL
liver	NULL
microsomes	NULL
by	NULL
ascorbic	NULL
acid	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

278:73-80	NULL
.	NULL

73	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Takahashi	NULL
,	NULL
and	NULL
E.	NULL
Niki	NULL
.	NULL

1987	NULL
.	NULL

Role	NULL
of	NULL
iron	NULL
and	NULL
ascorbic	NULL
acid	NULL
in	NULL
the	NULL
oxidation	NULL
of	NULL
methyl	NULL
linoleate	NULL
micelles	NULL
.	NULL

Chem	NULL
.	NULL

Lett	NULL
.	NULL

1149-1152	NULL
.	NULL

74	NULL
.	NULL

Bendich	NULL
,	NULL
A.	NULL
,	NULL
L.	NULL
J.	NULL
Machlin	NULL
,	NULL
O.	NULL
Scandurra	NULL
,	NULL
G.	NULL
W.	NULL
Burton	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
M.	NULL
Wayner	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
antioxidant	NULL
role	NULL
of	NULL
vitamin	NULL
C.	NULL
J	NULL
.	NULL

Free	NULL
Rad	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

2:419-444	NULL
.	NULL

75	NULL
.	NULL

Barber	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

1966	NULL
.	NULL

Lipid	NULL
peroxidation	NULL
in	NULL
rat	NULL
tissue	NULL
homogenates	NULL
:	NULL
Interaction	NULL
of	NULL
iron	NULL
and	NULL
ascorbic	NULL
acid	NULL
as	NULL
the	NULL
normal	NULL
catalytic	NULL
mechanism	NULL
.	NULL

Lipids	NULL
.	NULL

1:146-151	NULL
.	NULL

76	NULL
.	NULL

Sadrazadeh	NULL
,	NULL
S.	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Eaton	NULL
.	NULL

1988	NULL
.	NULL

Hemoglobin-mediated	NULL
oxidant	NULL
damage	NULL
to	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
requires	NULL
endogenous	NULL
ascorbate	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

82:1510-1515	NULL
.	NULL

77	NULL
.	NULL

Biemond	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
J.	NULL
G.	NULL
Swaak	NULL
,	NULL
H.	NULL
G.	NULL
Van	NULL
Eijk	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Koster	NULL
.	NULL

1988	NULL
.	NULL

Superoxide-dependent	NULL
release	NULL
from	NULL
ferritin	NULL
in	NULL
inflammatory	NULL
disease	NULL
.	NULL

Free	NULL
Radical	NULL
Biol	NULL
.	NULL

&	NULL
Med	NULL
.	NULL

4185-198	NULL
.	NULL

78	NULL
.	NULL

Jialal	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Grundy	NULL
.	NULL

1991	NULL
.	NULL

Preservation	NULL
of	NULL
endogenous	NULL
antioxidants	NULL
in	NULL
low	NULL
density	NULL
lipoprotein	NULL
by	NULL
ascorbate	NULL
but	NULL
not	NULL
probucol	NULL
during	NULL
oxidative	NULL
modifi-cation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:597-601	NULL
.	NULL

79	NULL
.	NULL

Négre-Salvayre	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Affany	NULL
,	NULL
C.	NULL
Hariton	NULL
,	NULL
and	NULL
R.	NULL
Salvayre	NULL
.	NULL

1991	NULL
.	NULL

Additional	NULL
antilipoperoxidant	NULL
activities	NULL
of	NULL
alpha-tocopherol	NULL
and	NULL
ascorbic	NULL
acid	NULL
on	NULL
mem-brane-like	NULL
systems	NULL
are	NULL
potentiated	NULL
by	NULL
rutin	NULL
.	NULL

Pharmacology	NULL
.	NULL

42:262-272	NULL
.	NULL

80	NULL
.	NULL

Frei	NULL
,	NULL
B.	NULL
,	NULL
L.	NULL
England	NULL
,	NULL
and	NULL
B.	NULL
N.	NULL
Ames	NULL
.	NULL

1989	NULL
.	NULL

Ascorbate	NULL
is	NULL
an	NULL
outstanding	NULL
antioxidant	NULL
in	NULL
human	NULL
blood	NULL
plasma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
.	NULL

86:6377-6381	NULL
.	NULL

81	NULL
.	NULL

Renkonen	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Mennander	NULL
,	NULL
J.	NULL
Ustinov	NULL
,	NULL
and	NULL
P.	NULL
Mattila	NULL
,	NULL
1990	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
is	NULL
crucial	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
ICAM-1	NULL
expression	NULL
on	NULL
endothelial	NULL
cells	NULL
by	NULL
interferon-gamma	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8:719-724	NULL
.	NULL

82	NULL
.	NULL

Lane	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
G.	NULL
E.	NULL
Lamkin	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Wancewicz	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
inhibitors	NULL
block	NULL
the	NULL
enhanced	NULL
expression	NULL
of	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
on	NULL
endothelial	NULL
cells	NULL
activated	NULL
by	NULL
interleukin-1	NULL
,	NULL
lipopolysaccharide	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

172:1273-1281	NULL
.	NULL

83	NULL
.	NULL

Myers	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
S.	NULL
N.	NULL
Desai	NULL
,	NULL
J.	NULL
Schembri-King	NULL
,	NULL
G.	NULL
L.	NULL
Letts	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Wallace	NULL
.	NULL

1992	NULL
.	NULL

Discriminatory	NULL
effects	NULL
of	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
and	NULL
calcium	NULL
ionophore	NULL
on	NULL
endothelial	NULL
ICAM-1	NULL
induction	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

262	NULL
:	NULL
C365-C373	NULL
.	NULL

84	NULL
.	NULL

Arleth	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Nambi	NULL
,	NULL
and	NULL
C.	NULL
P.	NULL
Sung	NULL
.	NULL

1992	NULL
.	NULL

Suppressive	NULL
action	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
on	NULL
intracellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
expression	NULL
in	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

FASEB	NULL
(	NULL
Fed	NULL
.	NULL

Am	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL
)	NULL

J.	NULL
A1890:5518	NULL
.	NULL

(	NULL
Abstr	NULL
.	NULL
)	NULL

85	NULL
.	NULL

Ritchie	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
D.	NULL
R.	NULL
Johnson	NULL
,	NULL
B.	NULL
M.	NULL
Ewenstein	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1991	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
induction	NULL
of	NULL
endothelial	NULL
cell	NULL
surface	NULL
antigens	NULL
is	NULL
independent	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
or	NULL
inactivation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:3056-3062	NULL
.	NULL

86	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Bacuerle	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
role	NULL
for	NULL
oxygen	NULL
radicals	NULL
as	NULL
second	NULL
messengers	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

1:39-42	NULL
.	NULL

87	NULL
.	NULL

Marui	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
K.	NULL
Offermann	NULL
,	NULL
R.	NULL
Swerlick	NULL
,	NULL
C.	NULL
Kunsch	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
M.	NULL
Ahmad	NULL
,	NULL
R.	NULL
W.	NULL
Alexander	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Medford	NULL
.	NULL

1993	NULL
.	NULL

Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
are	NULL
regulated	NULL
through	NULL
an	NULL
antioxidant-sensitive	NULL
mechanism	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

92:1866-1874	NULL
.	NULL

